Prof. OSMAN İLHAN

Articles 254

1. Clinical Manifestations, Treatment Characteristics, and Clinical Outcomes in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in a Real-World Setting: An Interim Analysis of the Turkish iTTP Registry

Karakuş S., Bakanay Ş. M., BEŞIŞIK S., EŞKAZAN A. E., Ayyıldız O., GÜRKAN E., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.42, no.3, pp.203-212, 2025 (SCI-Expanded, Scopus, TRDizin)

2. Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Lahmer T., Salmanton-García J., Marchesi F., El-Ashwah S., Nucci M., Besson C., et al.

Infection , vol.52, no.3, pp.1125-1141, 2024 (SCI-Expanded, Scopus)

3.

KOYUN D., YÜKSEL S., SEVAL G. C., BOZDAĞ S. C., TOPRAK S. K., TOPÇUOĞLU P., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.8, no.1, pp.39-45, 2024 (TRDizin)

4. Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

Mulder J. W., Tromp T. R., Al-Khnifsawi M., Blom D. J., Chlebus K., Cuchel M., et al.

JAMA Cardiology , vol.9, no.4, pp.313-322, 2024 (SCI-Expanded, Scopus)

5. The effect of danger-associated molecular patterns on survival in acute graft versus host disease

Çelik S., KAYNAR L., Güven Z. T., Atasever Duran K., KONTAŞ O., KEKLİK M., et al.

Bone Marrow Transplantation , vol.59, no.2, pp.189-195, 2024 (SCI-Expanded, Scopus)

6. Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry

Musto P., Salmanton-García J., Sgherza N., Bergantim R., Farina F., Glenthøj A., et al.

Hematological Oncology , vol.42, no.1, 2024 (SCI-Expanded, Scopus)

7. Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation

Merter M., Sahin U., İLHAN ., Beksac M.

Journal of Clinical Apheresis , vol.38, no.6, pp.685-693, 2023 (SCI-Expanded, Scopus)

8. The world apheresis association registry, 2023 update

Vrielink H., Le Poole K., Stegmayr B., Kielstein J., Berlin G., İLHAN ., et al.

Transfusion and Apheresis Science , vol.62, no.6, 2023 (SCI-Expanded, Scopus)

9. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

Rossi G., Salmanton-García J., Cattaneo C., Marchesi F., Dávila-Valls J., Martín-Pérez S., et al.

International Journal of Infectious Diseases , vol.137, pp.98-110, 2023 (SCI-Expanded, Scopus)

10. Vitamin D Gene Polymophism in Patients with Aseptic Necrosis after Allogeneic Hematopoietic Stem Cell Transplantation

SOYDAN E., ŞAHİN U., CEYLANER S., GÖKMEN A., DOĞAN H., OKCU M. K., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.7, no.2, pp.51-56, 2023 (TRDizin)

11. Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study

Arat M., Alacacioglu I., Bolaman A. Z., Buyukasik Y., Cagirgan S., Güvenc B., et al.

Future Oncology , vol.19, no.14, pp.975-982, 2023 (SCI-Expanded, Scopus)

12. Generic Lenalidomide Rivelime Versus Brand-name Revlimid® in the Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Single-center Experience on Efficacy, Safety and Survival Outcome

Beksac M., CENGİZ SEVAL G., Koyun D., TOPÇUOĞLU P., YÜKSEL M., Gurman G., et al.

Clinical Lymphoma, Myeloma and Leukemia , vol.23, no.3, 2023 (SCI-Expanded, Scopus)

13. Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center

CENGİZ SEVAL G., Bozdag S. C., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

Balkan Medical Journal , vol.40, no.3, pp.197-204, 2023 (SCI-Expanded, Scopus, TRDizin)

14. Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data

Kırcalı E., Seval G. C., Öztürk C., Yılmaz H., Koyun D., Bozdağ S. C., et al.

Balkan Medical Journal , vol.40, no.1, pp.51-56, 2023 (SCI-Expanded, Scopus, TRDizin)

15. Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry

Busca A., Salmanton-García J., Marchesi F., Farina F., Seval G. C., Van Doesum J., et al.

Frontiers in Immunology , vol.14, 2023 (SCI-Expanded, Scopus)

16. Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients

Gokmen A., Sahin U., Soydan E., Gokgoz Z., Okcu M. K., Ozan U., et al.

Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.10, 2022 (SCI-Expanded, Scopus)

17. Effect of CD34+ Total/Myeloid CD34+ Cell Progenitors and B-Lymphoid Progenitors Within the Bone Marrow Grafts on the Hematopoietic Recovery After Hematopoietic Stem Cell Transplantation

DALVA K., HASKOLOĞLU Z. Ş., DALVA AYDEMİR S., Oz M. D., ÖZTÜRK BİRGE A., Ipek S., et al.

Experimental and Clinical Transplantation , vol.20, no.10, pp.937-944, 2022 (SCI-Expanded, Scopus)

18. Prognostic factors in thrombotic thrombocytopenic purpura

Yalçıner M., İlhan O.

Turkish Journal of Biochemistry , vol.47, no.5, pp.626-632, 2022 (SCI-Expanded, Scopus, TRDizin)

19. Outcomes of Second Allogeneic Hematopoietik Transplant: Real Life Data

KIRCALI E., SEVAL G. C., ÖZTÜRK C., Yilmaz H., ŞENOYMAK M. C., ERMİŞ G. Y., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.6, no.2, pp.50-55, 2022 (TRDizin)

20. Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia

Ozdemir Z. N., Kircali E., Şahin U., Seval G. C., Bozdağ S. C., Toprak S. K., et al.

Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.8, pp.596-600, 2022 (SCI-Expanded, Scopus)

21. COVID-19 and hairy-cell leukemia: An EPICOVIDEHA survey

Lamure S., Salmanton-García J., Robin-Marieton E., Jaksic O., Kohn M., Marchesi F., et al.

Blood Advances , vol.6, no.13, pp.3870-3874, 2022 (SCI-Expanded, Scopus)

22. Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease

Koyun D., CENGİZ SEVAL G., Kırcalı E., Bozdağ S. C., TOPRAK S. K., TOPÇUOĞLU P., et al.

Indian Journal of Hematology and Blood Transfusion , vol.38, no.3, pp.601-605, 2022 (SCI-Expanded, Scopus)

23. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Soran H., Freiberger T., Harada-Shiba M., Cuchel M., Tromp T. R., Tromp T. R., et al.

The Lancet , vol.399, no.10326, pp.719-728, 2022 (SCI-Expanded, Scopus)

24. Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial

Garcia-Manero G., Mufti G. J., Fenaux P., Buckstein R., Santini V., Díez-Campelo M., et al.

Blood , vol.139, no.4, pp.624-629, 2022 (SCI-Expanded, Scopus)

25. Lipoprotein apheresis efficacy and challenges: single center experience

Özdemir Z. N., Şahin U., Yıldırım Y., TULUNAY KAYA C., İLHAN .

Hematology, Transfusion and Cell Therapy , vol.44, no.1, pp.56-62, 2022 (ESCI, Scopus)

26. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies COVID-19 Geçiren Türk Hematolojik Malignite Hastalarının Klinik Özellikleri ve Sonuçları

Bozdağ S. C., Seval G. C., Hindilerden İ. Y., Hindilerden F., Andıç N., Baydar M., et al.

Turkish Journal of Hematology , vol.39, no.1, pp.43-54, 2022 (SCI-Expanded, Scopus, TRDizin)

27. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Pagano L., Salmanton-García J., Marchesi F., Busca A., Corradini P., Hoenigl M., et al.

Journal of Hematology and Oncology , vol.14, no.1, 2021 (SCI-Expanded, Scopus)

28. Implementation of geriatric haematology programmes for the treatment of older people with haematological malignancies in low-resource settings

Soto-Perez-de-Celis E., Martínez-Peromingo J., Chávarri-Guerra Y., Loh K. P., Demichelis-Gómez R., Rodrigues M., et al.

The Lancet Healthy Longevity , vol.2, no.11, 2021 (ESCI, Scopus)

29. Analysis of extracorporeal photopheresis within the frame of the WAA register

Blaha M., Gasova Z., Berlin G., Audzijoniene J., Griskevicius A., Dykes J., et al.

Transfusion and Apheresis Science , vol.60, no.5, 2021 (SCI-Expanded, Scopus)

30. Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor-discontinuation” in chronic myeloid leukemia

İLHAN ., Narli Ozdemir Z., DALVA K., Arslan A., Okay Ozgeyik M., Ipek S., et al.

International Journal of Laboratory Hematology , vol.43, no.5, pp.1110-1116, 2021 (SCI-Expanded, Scopus)

31. Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis

Stegmayr B., Newman E., Witt V., Derfler K., Leitner G., Eloot S., et al.

Transfusion Medicine and Hemotherapy , vol.48, no.4, pp.234-239, 2021 (SCI-Expanded, Scopus)

32. Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis

Karadag F. K., YENEREL M. N., YILMAZ M., uskudar T. H., ÖZKOCAMAN V., Tuglular T., et al.

American journal of Blood Research , vol.11, no.3, pp.279-285, 2021 (Peer-Reviewed Journal)

33. Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study

Stilgenbauer S., Bosch F., İLHAN ., Kisro J., Mahé B., Mikuskova E., et al.

British Journal of Haematology , vol.193, no.2, pp.325-338, 2021 (SCI-Expanded, Scopus)

34. Brentuksimab Vedotin Treatment in Relaps Refractory Hodgkin Lymphoma: A Single Center Experience

KOYUN D., SEVAL G. C., SÖKMEN M., AKKUŞ E., ATİLLA E., BOZDAĞ S. C., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.5, no.1, pp.1-4, 2021 (TRDizin)

35. The Efficacy of Therapeutic Thrombocytapheresis in Patients with Thrombocytosis

ÖZDEMİR Z. N., ŞAHİN U., BOZDAĞ S. C., YÜKSEL M. K., TOPRAK S. K., TOPÇUOĞLU P., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.74, no.3, pp.278-282, 2021 (TRDizin)

36. Acute Kidney Injury Due to Leukemic Infiltration in a Patient with Chronic Lymphocytic Leukemia

Şahin G. K., Kocabay H. E., Kiremitçi S., İlhan O., Keven K.

Turkish Journal of Hematology , vol.38, no.2, pp.167-168, 2021 (SCI-Expanded, Scopus, TRDizin)

37. Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy

Narli Ozdemir Z., Cengiz Seval G., Sahin U., Uslu A., Gunduz M., Civriz Bozdag S., et al.

Indian Journal of Hematology and Blood Transfusion , vol.37, no.1, pp.67-75, 2021 (SCI-Expanded, Scopus)

38. Acute kidney injury due to leukemic infiltration in a patient with chronic lymphocytic leukemia Kronik lenfositik lösemide lösemik infiltrasyona bağlı akut böbrek yetmezliği

KUMRU G., Kocabay H. E., KİREMİTCİ S., İLHAN ., KEVEN K.

Turkish Journal of Hematology , vol.38, no.2, pp.167-168, 2021 (SCI-Expanded, Scopus, TRDizin)

39. Highlighting the prognostic importance of measurable residual disease among acute myeloid leukemia risk factors Akut myeloid lösemi risk faktörleri arasında ölçülebilir kalıntı hastalığın prognostik öneminin vurgulanması

Özdemir Z. N., Şahin U., Dalva K., Baltacı M. A., Uslu A., Öztürk C., et al.

Turkish Journal of Hematology , vol.38, no.2, pp.111-118, 2021 (SCI-Expanded, Scopus, TRDizin)

40. Our Approach in Allogeneic Stem Cell Transplantation: 11 Years of Experience

KIRCALI E., SEVAL G. C., BOZDAĞ S. C., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.4, no.3, pp.50-54, 2020 (TRDizin)

41. Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation

Ataca Atilla P., Akkus E., Atilla E., Gokmen N., Civriz Bozdag S., Kurt Yuksel M., et al.

Clinical Transplantation , vol.34, no.10, 2020 (SCI-Expanded, Scopus)

42. Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma

Beksac M., Aydin Y., Goker H., Turgut M., Besisik S. K., Cagirgan S., et al.

Clinical Lymphoma, Myeloma and Leukemia , vol.20, no.8, 2020 (SCI-Expanded, Scopus)

43. Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation Effets de l'incompatibilité ABO pour l'allogreffe de cellules souches hématopoïétiques

Ataca Atilla P., Akkus E., Atilla E., Gökmen İnan N., Civriz Bozdag S., Kocak Toprak S., et al.

Transfusion Clinique et Biologique , vol.27, no.3, pp.115-121, 2020 (SCI-Expanded, Scopus)

44. Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.73, no.2, pp.113-117, 2020 (TRDizin)

45. Myelodisplastik Sendromda Allojeneik Kök Hücre Nakli

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.73, no.2, pp.113-117, 2020 (TRDizin)

46. Evaluation of Patients With Myelodysplastic Syndromeby Ogata Scoring in Flow Cytometry: Pilot Study

ATİLLA E., Kırcalı E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAN H., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.4, no.3, pp.45-49, 2020 (TRDizin)

47. Our Approach in Allogeneic Stem CellTransplantation: 11 Years of Experience

Kırcalı E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.4, no.3, pp.50-54, 2020 (TRDizin)

48. Miyelodisplastik Sendrom HastalarınınAkan Hücre Ölçer ile Yapılan OgataSkorlaması Yoluyla Değerlendirilmesi:Pilot Çalışma

ATİLLA E., Kırcalı E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAN H., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.4, no.3, pp.45-49, 2020 (TRDizin)

49. Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)

Kuman Tunçel Ö., Kayıkçıoğlu M., Pırıldar Ş., Yılmaz M., Kaynar L., Aktan M., et al.

Journal of Clinical Lipidology , vol.14, no.3, pp.361, 2020 (SCI-Expanded, Scopus)

50. Our Treatment Approach to Hairy Cell Leukemia

ATACA ATİLLA P., ATİLLA E., KIRCALI E., TOPÇUOĞLU P., DEMİRER T., ARSLAN Ö., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.73, no.1, pp.5-8, 2020 (TRDizin)

51. Tüylü Hücreli Lösemide Tedavi Yaklaşımımız

ATACA ATİLLA P., ATİLLA E., Kırcalı E., TOPÇUOĞLU P., DEMİRER T., ARSLAN Ö., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.73, no.1, pp.5-8, 2020 (TRDizin)

52. Luspatercept in patients with lower-risk myelodysplastic syndromes

Fenaux P., Platzbecker U., Mufti G. J., Garcia-Manero G., Buckstein R., Santini V., et al.

New England Journal of Medicine , vol.382, no.2, pp.140-151, 2020 (SCI-Expanded, Scopus)

53. Who 2016 definition of chronic myeloid leukemia and tyrosine kinase inhibitors Kronik myeloid lösemi who 2016 tanımlaması ve tirozin kinaz inhibitörleri

HAZNEDAROĞLU İ. C., KUZU I., İLHAN .

Turkish Journal of Hematology , vol.37, no.1, pp.42-47, 2020 (SCI-Expanded, Scopus, TRDizin)

54. Study for the diagnostic screening of paroxysmal nocturnal hemoglobinuria in older patients with unexplained anemia and/or cytopenia

Ozdemir Z. N., İLHAN ., Ozet G., Falay M., YENEREL M. N., Tuglular T., et al.

Clinical Laboratory , vol.66, no.9, pp.1709-1715, 2020 (SCI-Expanded, Scopus)

55. Impact of Hepatitis B Core Antibody Seropositivity on the Liver Function Tests After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.3, no.3, pp.55-59, 2019 (TRDizin)

56. Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients

İLHAN ., Ozdemir Z. N., Ozet G., Falay M., Yenerel M., Tuglular T., et al.

Transfusion and Apheresis Science , vol.58, no.5, pp.659-662, 2019 (SCI-Expanded, Scopus)

57. Evaluation of health and quality of life in apheresis patients – data from the WAA register

Goto J., Newman E., Witt V., Deeren D., Blaha M., Lanska M., et al.

Transfusion and Apheresis Science , vol.58, no.5, pp.641-644, 2019 (SCI-Expanded, Scopus)

58. Who 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors

Haznedaroğlu İ. C., Kuzu I., İLHAN O.

TURKISH JOURNAL OF HAEMATOLOGY , 2019 (SCI-Expanded, Scopus, TRDizin)

59. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Dagnew A. F., İLHAN ., Lee W., Woszczyk D., Kwak J., Bowcock S., et al.

The Lancet Infectious Diseases , vol.19, no.9, pp.988-1000, 2019 (SCI-Expanded, Scopus)

60. A CD34+ Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System

Kilic P., Bay M., Yildirim Y., Coskun O., Seker S., Baydin P., et al.

Cells Tissues Organs , vol.207, no.1, pp.15-20, 2019 (SCI-Expanded, Scopus)

61. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)

Kayikcioglu M., Kuman-Tunçel O., Pirildar S., Yílmaz M., Kaynar L., Aktan M., et al.

Journal of Clinical Lipidology , vol.13, no.3, pp.455-467, 2019 (SCI-Expanded, Scopus)

62. Comparison of the methods evaluating post thawing viability of peripheral blood stem cell graft

Varan H. D., BAY M., ÖZTÜRK BİRGE A., DALVA K., İLHAN .

Transfusion and Apheresis Science , vol.58, no.2, pp.192-195, 2019 (SCI-Expanded, Scopus)

63. HEMATOPOIETIC STEM CELL MOBILIZATION RESULTS WITH INTERMEDIATE DOSE (2.5 g/m2 Cy) CYCLOPHOSPHOMIDE IN THE MULTIPLE MYELOMA PATIENTS AT OUR INSTITUTE

GÖKGÖZ Z., SOYDAN E., GÖKMEN A., İLHAN O., ARSLAN Ö., ÖZCAN M.

İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.23, no.3, pp.184-189, 2019 (TRDizin)

64. Early initiation of extracorporeal photochemotherapy increases response for chronic graft versus host disease following steroid failure L'initiation précoce de la photochimiothérapie extracorporelle augmente la réponse pour la maladie chronique du greffon contre l'hôte après échec des stéroïdes

Gunduz M., Atilla E., Atilla P., TOPÇUOĞLU P., İLHAN .

Transfusion Clinique et Biologique , vol.26, no.1, pp.32-37, 2019 (SCI-Expanded, Scopus)

65. The Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Transplantation for Acute Leukemia

ŞAHİN U., ERDAL H., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.3, no.1, pp.9-13, 2019 (Peer-Reviewed Journal)

66. Akut Lösemide Allojeneik Nakil Öncesi Serum Ferritin Düzeyinin Nakil Sonuçlarına Etkisi

ŞAHİN U., HASAN E., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.3, no.1, pp.1-3, 2019 (Peer-Reviewed Journal)

67. Evaluation of the results of MOTAKK hepatitis C virus RNA genotyping and hepatitis delta virus external quality assessment programs during 2015-2016

Karatayli E., Soydemir E., Aksoy Z. B., Kizilpinar M., Koçak A. A., Karatayli S. C., et al.

Turkish Journal of Gastroenterology , vol.30, no.11, pp.957-963, 2019 (SCI-Expanded, Scopus, TRDizin)

68. Promising utilization areas of therapeutic plasmapheresis in cardiovascular surgery practice

Durdu M. S., Cakici M., Gumus F., Deniz G. C., Bozdag S. C., ÖZÇINAR E., et al.

Transfusion and Apheresis Science , vol.57, no.6, pp.762-767, 2018 (SCI-Expanded, Scopus)

69. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up

Saydam G., Haznedaroglu I. C., Kaynar L., Yavuz A. S., Ali R., Guvenc B., et al.

Hematology , vol.23, no.10, pp.771-777, 2018 (SCI-Expanded, Scopus)

70. Kronik Lenfositik Lösemi’de Tanı Anında Hipogammaglobulinemi Sağkalım ve Enfeksiyon Riski Üzerine Etklili Midir?

ATİLLA E., Özel F., ATACA ATİLLA P., TOPÇUOĞLU P., AKAN H., BEKSAÇ M., et al.

Kırıkkale Üniversitesi Tıp Fakültesi Dergisi , vol.20, no.3, 2018 (TRDizin)

71. Evaluation of 2015-2016 MOTAKK HBV DNA and HCV RNA external quality assessment national program results MOTAKK HBV DNA ve HCV RNA diş kalite kontrol ulusal programi 2015-2016 sonuçlarinin deǧerlendirilmesi

Karatayli E., Soydemir E., Aksoy Z. B., Kizilpinar M., Altay Koçak A., Karatayli S. C., et al.

Mikrobiyoloji Bulteni , vol.52, no.4, pp.348-366, 2018 (SCI-Expanded, Scopus, TRDizin)

72. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?

Kayikcioglu M., Tokgozoglu L., Dogan V., Ceyhan C., Tuncez A., Kutlu M., et al.

Atherosclerosis , vol.277, pp.341-346, 2018 (SCI-Expanded, Scopus)

73. KRONİK LENFOSİTİK LÖSEMİ’DE TANI ANINDAHİPOGAMMAGLOBULİNEMİSAĞKALIM VE ENFEKSİYON RİSKİ ÜZERİNDE ETKİLİ MİDİR?

ATİLLA E., ÖZEL F., ATACA ATİLLA P., TOPÇUOĞLU P., AKAN H., BEKSAÇ M., et al.

Kırıkkale Üniversitesi Tıp Fakültesi Dergisi , vol.20, no.3, pp.294-299, 2018 (TRDizin)

74. Primer Mediastinal Büyük B Hücreli Lenfoma Hastalarımızın Tedavi Sonuçlarının Geriye Dönük Değerlendirilmesi

ATİLLA E., ATACA ATİLLA P., CENGİZ SEVAL G., TOPRAK S. K., İLHAN O., ARSLAN Ö., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.2, no.3, 2018 (TRDizin)

75. Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience af a Single Center

ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., DALVA K., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.2, no.4, pp.93-97, 2018 (TRDizin)

76. Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study

Stilgenbauer S., Leblond V., Foà R., Böttcher S., İLHAN ., Knauf W., et al.

Leukemia , vol.32, no.8, pp.1778-1786, 2018 (SCI-Expanded, Scopus)

77. Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response

NARLI ÖZDEMİR Z., USLU A., TOPRAK S. K., TOPÇUOĞLU P., DALVA K., İLHAN O.

Hematological Disease and Therapies , 2018 (Peer-Reviewed Journal)

78. Biography

İLHAN .

Transfusion and Apheresis Science , vol.57, no.2, pp.151, 2018 (SCI-Expanded, Scopus)

79. JACIE: A 20 year-old voluntary body functioning worldwide

YÜKSEL M., İLHAN .

Transfusion and Apheresis Science , vol.57, no.2, pp.153-158, 2018 (SCI-Expanded, Scopus)

80. Kronik Lenfositik Lösemi’de Allojeneik Kök Hücre Nakli Deneyimi

ATİLLA E., PEKCAN G., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.71, no.1, pp.43-46, 2018 (TRDizin)

81. Allogeneic Stem Cell Transplantation Experience in Chronic Lymphocytic Leukemia

ATİLLA E., Pekca G., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.71, no.1, pp.43-46, 2018 (TRDizin)

82. Editorial

İLHAN .

Transfusion and Apheresis Science , vol.57, no.2, pp.150, 2018 (SCI-Expanded, Scopus)

83. Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: Primary analysis of the randomized, open-label mable study

Michallet A., Aktan M., Hiddemann W., İLHAN ., Johansson P., Laribi K., et al.

Haematologica , vol.103, no.4, pp.698-706, 2018 (SCI-Expanded, Scopus)

84. Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience

Atilla P. A., Atilla E., Bozdag S. C., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

Hematology/ Oncology and Stem Cell Therapy , vol.11, no.1, pp.13-17, 2018 (Scopus)

85. Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

HEMATOLOGY/ONCOLOGY AND STEM CELL THERAPY , vol.11, no.1, pp.13-17, 2018 (Scopus)

86. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

Kayikcioglu M., Tokgozoglu L., Yilmaz M., Kaynar L., Aktan M., Durmuş R. B., et al.

Atherosclerosis , vol.270, pp.42-48, 2018 (SCI-Expanded, Scopus)

87. Multiple Arterial Thrombosis Related with Cantharidin Ingestion

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., İLHAN O.

CASE REPORTS IN HEMATOLOGY , vol.2018, no.8159093, pp.1-3, 2018 (Peer-Reviewed Journal)

88. Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?

Atilla E., Yalciner M., Atilla P. A., Ates C., Bozdag S. C., Yuksel M. K., et al.

Antiviral Therapy , vol.23, no.8, pp.647-653, 2018 (SCI-Expanded, Scopus)

89. Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: A retrospective study

Atilla E., Sahin D., Atilla P. A., DOLAPÇI G. İ., TEKELİ F. A., Bozdag S. C., et al.

Antiviral Therapy , vol.23, no.6, pp.523-527, 2018 (SCI-Expanded, Scopus)

90. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia

Ozdogan H., GÜR DEDEOĞLU B., Oztemur Islakoglu Y., Aydos A., KÖSE S., ATALAY A., et al.

Leukemia Research , vol.63, pp.62-71, 2017 (SCI-Expanded, Scopus)

91. Extracorporeal photochemotherapy in mycosis fungoides Photochimiothérapie extracorporelle dans les mycoses fongiques

Atilla E., Atilla P., Bozdag S., Yuksel M., Toprak S., Topcuoglu P., et al.

Transfusion Clinique et Biologique , vol.24, no.4, pp.454-457, 2017 (SCI-Expanded, Scopus)

92. Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: The randomized MabEase study

Lugtenburg P., Avivi I., Berenschot H., İLHAN ., Marolleau J. P., Nagler A., et al.

Haematologica , vol.102, no.11, pp.1913-1922, 2017 (SCI-Expanded, Scopus)

93. Subsequent malignancies after allogeneic hematopoietic stem cell transplantation

Gündüz M., Özen M., Şahin U., Toprak S. K., Civriz Bozdağ S., Kurt Yüksel M., et al.

Clinical Transplantation , vol.31, no.7, 2017 (SCI-Expanded, Scopus)

94. Multipl myelomalı yaşlı hastaların klinik karakterleri ve tedavi sonuçları: Çok merkezli retrospektif çalışma

TERZİ H., KORKMAZ S., BERBER İ., KEKLİK M., DOĞU M. H., ŞENCAN M., et al.

Cumhuriyet Tıp Dergisi (ELEKTRONİK) , vol.39, no.1, pp.389-395, 2017 (TRDizin)

95. Kronik Miyeloproliferatif Neoplazi Tanılı Türk Hastaların Geriye Dönük ve Çok Merkezli Analizi

SOYER N., HAZNEDAROĞLU İ. C., CÖMERT M., ÇEKDEMİR D., YILMAZ M., ÜNAL A., et al.

Turkish Journal of Hematology , vol.34, no.1, pp.27-33, 2017 (SCI-Expanded, Scopus, TRDizin)

96. Kronik Myeloit Lösemide Allojenik Nakil ve Tirozin Kinaz İnhibitörlerinin Sağkalıma Etkisi Bir Öncesi-Sonrası Çalışması

ÖZEN M., ÜSTÜN C., ÖZTÜRK B., TOPÇUOĞLU P., ARAT M., GÜNDÜZ M., et al.

Turkish Journal of Hematology , vol.34, no.1, pp.16-26, 2017 (SCI-Expanded, Scopus, TRDizin)

97. The effect of age on peripheral stem cell mobilization in healthy donors, single center experience

Ozen M., Gunduz M., TOPÇUOĞLU P., TOPRAK S. K., DALVA K., Gurman G., et al.

Journal of Clinical Apheresis , vol.32, no.1, pp.16-20, 2017 (SCI-Expanded, Scopus)

98. Constitutional Trisomy 8 Mosaicism with Persistent Macrocytosis

Altlner Ş., KUTLAY N., İLHAN .

Cytogenetic and Genome Research , vol.150, no.1, pp.35-39, 2017 (SCI-Expanded, Scopus)

99. Multicenter retrospective analysis of turkish patients with chronic myeloproliferative neoplasms Kronik miyeloproliferatif neoplazi tanılı türk hastaların geriye dönük ve çok merkezli analizi

Soyer N., HAZNEDAROĞLU İ. C., Cömert M., Çekdemir D., Yılmaz M., ÜNAL A., et al.

Turkish Journal of Hematology , vol.34, no.1, pp.27-33, 2017 (SCI-Expanded, Scopus, TRDizin)

100. Allogeneic transplantation in chronic myeloid leukemia and the effect of tyrosine kinase inhibitors on survival: A quasi-experimental study Kronik myeloit lösemide allojenik nakil ve tirozin kinaz inhibitörlerinin sağkalıma etkisi bir öncesi-sonrası çalışması

Özen M., Üstün C., Öztürk B., Topçuoğlu P., Arat M., Gündüz M., et al.

Turkish Journal of Hematology , vol.34, no.1, pp.16-26, 2017 (SCI-Expanded, Scopus, TRDizin)

101. B-Hücreli Lenfoproliferatif Hastalıkların Dönüm Noktası İdelalisib

AKSU S., AYYILDIZ O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.

Uluslararası Hematoloji-Onkoloji Dergisi , vol.26, no.Suppl 1, pp.12-19, 2016 (SCI-Expanded, Scopus, TRDizin)

102. Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study

O'Brien S., Jones J. A., Coutre S. E., Mato A. R., Hillmen P., Tam C., et al.

The Lancet Oncology , vol.17, no.10, pp.1409-1418, 2016 (SCI-Expanded, Scopus)

103. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase

Saydam G., Haznedaroglu I. C., Kaynar L., Yavuz A. S., Ali R., Guvenc B., et al.

Expert Opinion on Pharmacotherapy , vol.17, no.14, pp.1851-1858, 2016 (SCI-Expanded, Scopus)

104. İnşaat Esnasında Hematoloji Hastalarında Gelişen Enfeksiyonların Önlenmesinde Portabl Yüksek Etkinlikte Partikül Emici Filtrelerin Etkinliğinin Değerlendirildiği Bir Öncesi Sonrası Çalışması

ÖZEN M., YILMAZ G., COŞKUN B., TOPÇUOĞLU P., ÖZTÜRK B., GÜNDÜZ M., et al.

Turkish Journal of Hematology , vol.33, no.1, pp.41-47, 2016 (SCI-Expanded, Scopus, TRDizin)

105. Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates

Tekgündüz E., Şencan I., Kapuağasi A., Ünal D., Öztürk M., Gümüş E., et al.

Transfusion and Apheresis Science , vol.54, no.1, pp.53-59, 2016 (SCI-Expanded, Scopus)

106. A quasi-experimental study analyzing the effectiveness of portable high-efficiency particulate absorption filters in preventing infections in hematology patients during construction İnşaat esnasında hematoloji hastalarında gelişen enfeksiyonların önlenmesinde portabl yüksek etkinlikte partikül emici filtrelerin etkinliğinin değerlendirildiği bir öncesi sonrası Çalışması

Özen M., Yılmaz G., Coşkun B., Topçuoğlu P., Öztürk B., Gündüz M., et al.

Turkish Journal of Hematology , vol.33, no.1, pp.41-47, 2016 (SCI-Expanded, Scopus, TRDizin)

107. Idelalisib at the crossroads of B-cell lymphoproliferative disorders B-Hücreli lenfoproliferatif hastalıkların dönüm noktası İdelalisib

AKSU S., Ayyildiz O., Etgul S., GÖKER H., Gunes G., HAZNEDAROĞLU İ. C., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.26, pp.12-19, 2016 (SCI-Expanded, Scopus, TRDizin)

108. Steroide Dirençli Akut Graft Versus Host Hastalığının Tedavisinde Antilenfosit / Timosit Globulin: Bir Merkezdeki 20 Yıllık Deneyim

ÖZEN M., BOZDAG S. C., CAKMAK G., TOPÇUOĞLU P., EROGLU A. H., GÜNDÜZ M., et al.

Uluslararası Hematoloji-Onkoloji Dergisi , vol.25, no.4, pp.236-244, 2015 (SCI-Expanded, Scopus, TRDizin)

109. Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting

CAN A., Ulus A. T., ÇINAR Ö., TOPAL ÇELİKKAN F., Simsek E., AKYOL M., et al.

Stem Cell Reviews and Reports , vol.11, no.5, pp.752-760, 2015 (SCI-Expanded, Scopus)

110. Peripheral blood stem cell mobilization and collection from elderly patients and elderly healthy donor

Bozdag S. C., İLHAN .

Transfusion and Apheresis Science , vol.53, no.1, pp.8-12, 2015 (SCI-Expanded, Scopus)

111. Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: Results of the randomized NHL13 trial

Jaeger U., Trneny M., Melzer H., Praxmarer M., Nawarawong W., Yehuda D. B., et al.

Haematologica , vol.100, no.7, pp.955-963, 2015 (SCI-Expanded, Scopus)

112. Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study

Korkmaz S., Dal M. S., Berber I., Sahin D. G., Dogu M. H., Ayyildiz O., et al.

Geriatrics and Gerontology International , vol.15, no.6, pp.729-735, 2015 (SCI-Expanded, SSCI, Scopus)

113. Hyperviscosity in renal transplant recipients

Tutal E., Erkmen Uyar M., Uyanik S., Bal Z., Guliyev O., TOPRAK S. K., et al.

Transplantation Proceedings , vol.47, no.4, pp.1165-1169, 2015 (SCI-Expanded, Scopus)

114. Antilymphocyte/thymocyte globulin for the treatment of steroid-refractory acute graft-versus-host disease: 20-year experience at a single center Steroide dirençli akut graft versus host hastalığının tedavisinde antilenfosit / Timosit globulin: Bir merkezdeki 20 yıllık deneyim

Ozen M., Bozdag S. C., Cakmak G., TOPÇUOĞLU P., EROĞLU A. H., Gunduz M., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.25, no.4, pp.236-244, 2015 (SCI-Expanded, Scopus, TRDizin)

115. Clinical characteristics, post-treatment assessment and prognostic factors affecting patient survival of patients at 65 years of age or older with hodgkin lymphoma: A retrospective multicenter study from Turkey

Berber I., Erkurt M. A., Keklik M., Dogu M. H., Terzi H., Pala C., et al.

Acta Medica Mediterranea , vol.31, no.6, pp.1195-1202, 2015 (SCI-Expanded, Scopus)

116. Therapeutic plasmapheresis in geriatric patients: Favorable results

Ataca P., Marasuna O. A., Ayyildiz E., BAY M., İLHAN .

Transfusion and Apheresis Science , vol.51, no.3, pp.64-67, 2014 (SCI-Expanded, Scopus)

117. Quilty Effect after Extracorporeal Photopheresis in a Patient with Severe Refractory Cardiac Allograft Rejection

ÖZCAN Ö. U., SAYIN T., SÖĞÜT G., HEPER A., GÖKSÜLÜK H., VURGUN V. K., et al.

Turkish Journal of Hematology , vol.31, no.4, pp.90-91, 2014 (SCI-Expanded, Scopus, TRDizin)

118. -

AYYILDIZ O., DEMİRKAN F., GÖKER H., HAZNEDAROĞLU İ. C., İLHAN O., KAYNAR L. G., et al.

Uluslararası Hematoloji-Onkoloji Dergisi , vol.253, pp.4-14, 2014 (SCI-Expanded, Scopus, TRDizin)

119. The treatment of acquired hemophilia with combination therapy of immunosuppressives and immunoadsorption Kazani{dotless}lmi{dotless}ş hemofilinin immunsupresif ve immunadsorbsiyon kombinasyonu ile tedavisi

Bilgin A. U., ÖZCAN M., Ayyildiz E., İLHAN .

Turkish Journal of Hematology , vol.31, no.2, pp.194-196, 2014 (SCI-Expanded, Scopus, TRDizin)

120. Ibrutinib: From Molecule to Medicine İbrutinib: Molekülden İlaca

Ayyildiz O., Demirkan F., GÖKER H., HAZNEDAROĞLU İ. C., İLHAN ., KAYNAR L., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.24, no.3, pp.4-14, 2014 (SCI-Expanded, Scopus, TRDizin)

121. Quilty effect after extracorporeal photopheresis in a patient with severe refractory cardiac allograft rejection Şiddetli Kardiyak Allogreft Rejeksiyonu Olan Bir Hastada Ekstrakorporeal Fotoferez Sonrası Quilty Etkisi

Özcan Ö. U., SAYIN T., Soğut G., HEPER A., Göksülük H., Vurgun V. K., et al.

Turkish Journal of Hematology , vol.31, no.4, pp.430-431, 2014 (SCI-Expanded, Scopus, TRDizin)

122. RHuEPO hyporesponsiveness and related high dosages are associated with hyperviscosity in maintenance hemodialysis patients

Erkmen Uyar M., TOPRAK S. K., Saglam H., Tutal E., BAY M., İLHAN ., et al.

The Scientific World Journal , vol.2013, 2013 (SCI-Expanded, Scopus)

123. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study

Korkmaz S., Keklik M., Sivgin S., Yildirim R., Tombak A., Kaya M. E., et al.

Transfusion and Apheresis Science , vol.48, no.3, pp.353-358, 2013 (SCI-Expanded, Scopus)

124. Double filtration plasmapheresis for a case of Crimean-Congo hemorrhagic fever

MEÇO B. C., MEMİKOĞLU K. O., İLHAN ., Ayyildiz E., Gunt C., ÜNAL M. N., et al.

Transfusion and Apheresis Science , vol.48, no.3, pp.331-334, 2013 (SCI-Expanded, Scopus)

125. Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis

Kaya E., Keklik M., Şencan M., Yilmaz M., Keskin A., Kiki I., et al.

Transfusion and Apheresis Science , vol.48, no.3, pp.349-352, 2013 (SCI-Expanded, Scopus)

126. Review of therapeutic options and the management of patients with myelodysplastic syndromes

Özcan M. A., İLHAN ., Ozcebe O. I., Nalcaci M., Gülbas Z.

Expert Review of Hematology , vol.6, no.2, pp.165-189, 2013 (SCI-Expanded, Scopus)

127. Türk kronik myeloid lösemi çalışması: KML hastalarının geriye dönük kesitsel incelenmesi

ŞAHİN F., SAYDAM G., CÖMERT M., UZ B., YAVUZ A. S., TURAN E., et al.

Turkish Journal of Hematology , vol.30, no.4, pp.351-358, 2013 (SCI-Expanded, Scopus, TRDizin)

128. Adsorptive leukocytapheresis in inflammatory bowel diseases: Our preliminary results are encouraging

TÖRÜNER M., TOPRAK S. K., MIZRAK K., YILDIRIM Y., BAY M., AYYILDIZ E., et al.

Turkish Journal of Hematology , vol.30, no.2, pp.219-220, 2013 (SCI-Expanded, Scopus, TRDizin)

129. Adsorptive leukocytapheresis in inflammatory bowel diseases: Our preliminary results are encouraging İnfl amatuvar Barsak Hastalıklarında Adzorptif Lo̧kositaferez Uygulamas?: Ïlk Sonuçlarımız Oldukça Cesaret Verici

TÖRÜNER M., TOPRAK S. K., Mizrak K., Yildirim Y., BAY M., Ayyildiz E., et al.

Turkish Journal of Hematology , vol.30, no.2, pp.219-220, 2013 (SCI-Expanded, Scopus, TRDizin)

130. The use of complementary and alternative medicine by the stem cell transplantation patients

KARACAN Y., AKKUŞ Y., AKDEMİR N., GÖKER H., AKSU S., SUCAK A. G., et al.

Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.38, no.1, pp.1-6, 2012 (TRDizin)

131. Plerixafor use in patients with previous mobilization failure: A multicenter experience

Tekgündüz E., Altuntaş F., Şivgin S., Aki Ş. Z., Dönmez A., Topçuoĝlu P., et al.

Transfusion and Apheresis Science , vol.47, no.1, pp.77-80, 2012 (SCI-Expanded, Scopus)

132. Older age and capacity of colony forming unit in autologous peripheral derived hematopoietic cells

Civriz Bozdag S., BAY M., Ayyildiz E., TOPÇUOĞLU P., İLHAN .

Transfusion and Apheresis Science , vol.47, no.1, pp.113-116, 2012 (SCI-Expanded, Scopus)

133. Turkish Apheresis Activity for 2011

ALTUNTAŞ F., Unal A., İLHAN .

Transfusion and Apheresis Science , vol.47, no.1, pp.57-58, 2012 (SCI-Expanded, Scopus)

134. Impact of age and diagnosis on viability during centrifugation and cryopreservation of peripheral blood stem cell products

Civriz Bozdag S., BAY M., Ayyildiz E., TOPÇUOĞLU P., İLHAN .

Transfusion and Apheresis Science , vol.47, no.1, pp.117-120, 2012 (SCI-Expanded, Scopus)

135. Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients

TOPÇUOĞLU P., Arat M., ÖZCAN M., ARSLAN Ö., İLHAN ., Beksac M., et al.

Annals of Hematology , vol.91, no.4, pp.577-586, 2012 (SCI-Expanded, Scopus)

136. Therapeutic plasma exchange in an intensive care unit (ICU): A 10-year, single-center experience

OZANSOY A., CAN Ö., Oral M., ÜNAL M. N., Ayyildiz E., İLHAN ., et al.

Transfusion and Apheresis Science , vol.45, no.2, pp.161-166, 2011 (SCI-Expanded, Scopus)

137. The management of Chronic Myeloid Leukemia in the era of second generation tyrosine kinase Inhibitors

HAZNEDAROĞLU İ. C., Cetiner M., İLHAN .

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.21, no.2 SUPPL. 1, pp.1-3, 2011 (SCI-Expanded, Scopus, TRDizin)

138. Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: Results of a randomized multicenter phase III trial

Beksac M., Ali R., Ozcelik T., ÖZCAN M., Ozcebe O., BAYIK M. M., et al.

Leukemia Research , vol.35, no.3, pp.340-345, 2011 (SCI-Expanded, Scopus)

139. Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

Gupta V., Eapen M., Brazauskas R., Carreras J., Aljurf M., Gale R. P., et al.

Haematologica , vol.95, no.12, pp.2119-2125, 2010 (SCI-Expanded, Scopus)

140. The effect of CD34 count and clonogenic potential of hematopoietic stem cells on engraftment

Sari T., YÜKSEL M., TOPÇUOĞLU P., BAY M., Ayyildiz E., ÖZCAN M., et al.

Transfusion and Apheresis Science , vol.43, no.3, pp.315-320, 2010 (SCI-Expanded, Scopus)

141. The impact of levobupivagaine and bupivacaine on postoperative respiratory functions and pain management in thoracic epidural analgesia Bupivakain ve levobupivakain'in torakal epidural uygulamalarinda postoperatif solunum fonksiyonlari ve aǧri üzerine etkileri

Serin G., Göksu S., Koruk S., Şahin L., Gül R., İLHAN ., et al.

Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi , vol.16, no.3, pp.96-102, 2010 (Scopus)

142. Remission of severe autoimmune bullous disorders induced by long-term extracorporeal photochemotherapy

ŞANLI H., AKAY B. N., Ayyildiz E., Anadolu R., İLHAN .

Transfusion and Apheresis Science , vol.43, no.3, pp.353-359, 2010 (SCI-Expanded, Scopus)

143. Chronic myeloid leukemia: Practical issues in diagnosis, treatment and follow-up

Buyukasik Y., Haznedaroglu I. C., İLHAN .

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.20, no.2 SUPPL., pp.1-12, 2010 (SCI-Expanded, Scopus, TRDizin)

144. Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation

Shaughnessy P., Bolwell B., Van Besien K., Mistrik M., Grigg A., Dodds A., et al.

Bone Marrow Transplantation , vol.45, no.6, pp.1068-1076, 2010 (SCI-Expanded, Scopus)

145. Allogeneik hematopoietik hücre nakli sonrası sklerodermatoz tip graft-versus- host hastalığının klinik yönleri

ŞANLI H., AKAY B. N., SOYDAN E., KOÇYİĞİT P., ARAT M., İLHAN O.

Turkish Journal of Hematology , vol.27, no.2, pp.91-98, 2010 (Scopus, TRDizin)

146. Propofol/dexmedetomidine and propofol/ketamine combinations for anesthesia in pediatric patients undergoing transcatheter atrial septal defect closure: A prospective randomized study

Koruk S., Mizrak A., Kaya Ugur B., İLHAN ., Baspinar O., Oner U.

Clinical Therapeutics , vol.32, no.4, pp.701-709, 2010 (SCI-Expanded, Scopus)

147. Supratentorial kraniotomilerde dexmedetomidin' in yeri

İLHAN O., KORUK S., SERİN G., ERKUTLU İ., ÖNER Ü.

Eurasian Journal of Medicine , vol.42, no.2, pp.61-65, 2010 (TRDizin)

148. Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation Allogeneik hematopoietik hücre nakli sonrası sklerodermatoz tip graft-versus-host hastalıǧının klinik yönleri

ŞANLI H., AKAY B. N., SOYDAN E., KOÇYİĞİT P., Arat M., İLHAN .

Turkish Journal of Hematology , vol.27, no.2, pp.91-98, 2010 (Scopus, TRDizin)

149. The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: A pilot study

YÜKSEL M., TOPÇUOĞLU P., Kurdal M., İLHAN .

Cytotherapy , vol.12, no.1, pp.38-44, 2010 (SCI-Expanded, Scopus)

150. Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: A randomized evaluation of early vs late administration of recombinant human G-CSF

Ozcelik T., TOPÇUOĞLU P., Beksac M., ÖZCAN M. E., Arat M., Bykl Z., et al.

Bone Marrow Transplantation , vol.44, no.12, pp.779-783, 2009 (SCI-Expanded, Scopus)

151. Retrospective evaluation of patients treated with dasatinib for Philadelphia positive leukemias: Turkish experience of 16 months

Saydam G., Haznedaroglu I. C., Temiz Y., Soysal T., Sucak G., Tombuloglu M., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.19, no.4, pp.195-204, 2009 (Scopus, TRDizin)

152. Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia

Sayitoglu M., Haznedaroǧlu I. C., Hatirnaz O., Erbilgin Y., Aksu S., Koca E., et al.

Journal of International Medical Research , vol.37, no.4, pp.1018-1028, 2009 (SCI-Expanded, Scopus)

153. Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma

Fenske T. S., Hari P. N., Carreras J., Zhang M., Kamble R. T., Bolwell B. J., et al.

Biology of Blood and Marrow Transplantation , vol.15, no.11, pp.1455-1464, 2009 (SCI-Expanded, Scopus)

154. Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

Lee S. J., Kukreja M., Wang T., Giralt S. A., Szer J., Arora M., et al.

Blood , vol.112, no.8, pp.3500-3507, 2008 (SCI-Expanded, Scopus)

155. Clonal evolution of monosomy 7 in acquired severe aplastic anemia: Two cases treated with allogeneic hematopoietic stem cell transplantation

Bakanay Ş. M., TOPÇUOĞLU P., Bilgin A. U., Yararbaş K., Karaüzüm S. B., ÖZCAN M., et al.

Turkish Journal of Hematology , vol.25, no.2, pp.94-97, 2008 (Scopus, TRDizin)

156. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloblastic leukemia (AML): A single center experience

İLHAN ., TOPÇUOĞLU P., Arat M., SOYDAN E., YÜKSEL M., ARSLAN Ö., et al.

Turkish Journal of Hematology , vol.25, no.2, pp.87-93, 2008 (Scopus, TRDizin)

157. A case report of the Modified Malmö Protocol: An alternative therapeutic approach to refractory chronic idiopathic thrombocytopenic purpura

Yazman D., Konuk N., ÖZCAN M., Arat M., SOYDAN E., ARSLAN Ö., et al.

Therapeutic Apheresis and Dialysis , vol.12, no.3, pp.255-258, 2008 (SCI-Expanded, Scopus)

158. Vitiligo after hematopoietic cell transplantation: Six cases and review of the literature

ŞANLI H., AKAY B. N., Arat M., KOÇYİĞİT P., Akan H., Beksac M., et al.

Dermatology , vol.216, no.4, pp.349-354, 2008 (SCI-Expanded, Scopus)

159. HLA-Identical Sibling Allogeneic Transplants versus Chemotherapy in Acute Myelogenous Leukemia with t(8;21) in First Complete Remission: Collaborative Study between the German AML Intergroup and CIBMTR

Schlenk R. F., Pasquini M. C., Pérez W. S., Zhang M., Krauter J., Antin J. H., et al.

Biology of Blood and Marrow Transplantation , vol.14, no.2, pp.187-196, 2008 (SCI-Expanded, Scopus)

160. Comparison of different needle diameters and flow rates on bone marrow mononuclear stem cell viability: An ex vivo experimental study

BAY M., AKAR A. R., Durdu S., Ayyildiz E., İLHAN .

Cytotherapy , vol.10, no.1, pp.98-99, 2008 (SCI-Expanded, Scopus)

161. How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight

TOPÇUOĞLU P., SOYDAN E., Ekiz F., Ayyildiz E., DALVA K., ÖZCAN M., et al.

Transfusion and Apheresis Science , vol.36, no.3, pp.275-280, 2007 (SCI-Expanded, Scopus)

162. Novel chromosomal translocations in multiple myeloma: t(13;16)(q14;q24) and t(1;15)(q10;q26)

Akalin I., KUTLAY N., İLHAN ., Tukun A.

International Journal of Laboratory Hematology , vol.29, no.3, pp.215-220, 2007 (SCI-Expanded, Scopus)

163. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra

SOYDAN E., Ayyildiz E., DALVA K., TOPÇUOĞLU P., BAY M., ARSLAN Ö., et al.

Transfusion and Apheresis Science , vol.36, no.3, pp.269-273, 2007 (SCI-Expanded, Scopus)

164. Effects of plasma nitric oxide levels on platelet activation in single donor apheresis and random donor concentrates

Büyükkaǧnici D. I., İLHAN ., Kavas G. Ö., ARSLAN Ö., Arat M., DALVA K., et al.

Transfusion and Apheresis Science , vol.36, no.1, pp.73-78, 2007 (SCI-Expanded, Scopus)

165. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: Review of 50 cases

YÜCESAN C., Arslan Ö., Arat M., Yücemen N., Ayyildiz E., İLHAN ., et al.

Transfusion and Apheresis Science , vol.36, no.1, pp.103-107, 2007 (SCI-Expanded, Scopus)

166. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD)

Ayyildiz E., ARSLAN Ö., TOPÇUOĞLU P., Arat M., DALVA K., SOYDAN E., et al.

Transfusion and Apheresis Science , vol.36, no.1, pp.79-85, 2007 (SCI-Expanded, Scopus)

167. Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest?

Bakanay S. M., DALVA K., Arat M., ARSLAN Ö., Ayyildiz E., Beksac M., et al.

Transfusion and Apheresis Science , vol.34, no.2, pp.171-178, 2006 (SCI-Expanded, Scopus)

168. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission

Tallman M. S., Pérez W. S., Lazarus H. M., Gale R. P., Maziarz R. T., Rowe J. M., et al.

Biology of Blood and Marrow Transplantation , vol.12, no.2, pp.204-216, 2006 (SCI-Expanded, Scopus)

169. Expression of IFITM1 in chronic myeloid leukemia patients

Akyerli C. B., Beksac M., Holko M., Frevel M., DALVA K., Özbek U., et al.

Leukemia Research , vol.29, no.3, pp.283-286, 2005 (SCI-Expanded, Scopus)

170. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation

DEMİRER T., Ayli M., Fen T., ÖZCAN M. E., Arat M., Buyukberber S., et al.

Bone Marrow Transplantation , vol.34, no.9, pp.781-786, 2004 (SCI-Expanded, Scopus)

171. Transfusion and Apheresis Science: Introduction

İLHAN .

Transfusion and Apheresis Science , vol.30, no.3, pp.179-180, 2004 (SCI-Expanded, Scopus)

172. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience

Arat M., ARSLAN Ö., Ayyildiz E., TOPÇUOĞLU P., DALVA K., İLHAN .

Transfusion and Apheresis Science , vol.30, no.3, pp.189-191, 2004 (SCI-Expanded, Scopus)

173. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease

İLHAN ., Arat M., ARSLAN Ö., Ayyildiz E., Sanli H., Beksac M., et al.

Transfusion and Apheresis Science , vol.30, no.3, pp.185-187, 2004 (SCI-Expanded, Scopus)

174. Therapeutic plasma exchange in a single center: Ibni Sina experience

ARSLAN Ö., Arat M., Tek I., Ayyildiz E., İLHAN .

Transfusion and Apheresis Science , vol.30, no.3, pp.181-184, 2004 (SCI-Expanded, Scopus)

175. Therapeutic angiogenesis by autologous transplantation of bone-marrow mononuclear cells for Buersger's patients with retractable limb ischaemia: A preliminary report

AKAR A. R., Durdu S., Arat M., Eren N. T., ARSLAN Ö., Çorapçioǧlu T., et al.

Turkish Journal of Haematology , vol.21, no.1, pp.13-21, 2004 (Scopus)

176. Effects of replacement fluids on plasma viscosity used for therapeutic plasma exchange

ARSLAN Ö., Tek I., Arat M., ÇİFTCİ İ., İLHAN .

Therapeutic Apheresis and Dialysis , vol.8, no.2, pp.144-147, 2004 (Scopus)

177. Simultaneous Onset of Chronic Graft Versus Host Disease and Alopecia Areata Following Allogeneic Haematopoietic Cell Transplantation [11]

ŞANLI H., Kusak F., Arat M., Ekmekci P., İLHAN .

Acta Dermato-Venereologica , vol.84, no.1, pp.86-87, 2004 (SCI-Expanded, Scopus)

178. Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure

Tek I., ARSLAN Ö., Arat M., Ayyildiz E., BAY M., Oral M., et al.

Transfusion and Apheresis Science , vol.31, no.2, pp.89-93, 2004 (SCI-Expanded, Scopus)

179. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy

Arat M., ARSLAN Ö., Gürman G., DALVA K., ÖZCAN M., Uǧur A., et al.

Transfusion and Apheresis Science , vol.30, no.1, pp.9-15, 2004 (SCI-Expanded, Scopus)

180. Autologous platelet collection and storage to support thrombocytopenia in a leukemia patient with platelet alloimmunization undergoing chemotherapy

YÜKSEL M., Arat M., ARSLAN Ö., Beksaç M., İLHAN .

Turkish Journal of Haematology , vol.20, no.4, pp.233-236, 2003 (Scopus)

181. The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia

KUTLAY S., Beksac M., DALVA K., İLHAN ., Koc H., Akan H., et al.

Leukemia and Lymphoma , vol.44, no.5, pp.791-795, 2003 (SCI-Expanded, Scopus)

182. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: A retrospective evaluation

DEMİRER T., Uysal V., Ayli M., Genc Y., İLHAN ., Koc H., et al.

Bone Marrow Transplantation , vol.31, no.9, pp.755-761, 2003 (SCI-Expanded, Scopus)

183. Role of pretransplant interferon-α(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): Results from three Turkish transplant centers

Beksac M., Çelebi H., Sargín D., Yalcin A., Topcuoglo P., Kalayoglu-Besisik S., et al.

Bone Marrow Transplantation , vol.31, no.10, pp.897-904, 2003 (SCI-Expanded, Scopus)

184. Clinical use of erythropoietin in patients with anemia due to radiotherapy Radyoterapi̇ alan anemi̇k hastalarda eri̇tropoeti̇n'i̇n kli̇ni̇k kullanimi

ALTUNTAŞ F., Arat M., İLHAN .

Erciyes Tip Dergisi , vol.25, no.1, pp.45-53, 2003 (Scopus, TRDizin)

185. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange

Tek I., ARSLAN Ö., Arat M., ÖZCAN M., Akdaǧ B., İLHAN .

Transfusion and Apheresis Science , vol.28, no.1, pp.3-7, 2003 (SCI-Expanded, Scopus)

186. Malpositioning of Hickman catheters, left versus right sided attempts

ÜNAL A. E., BAYAR S., Arat M., İLHAN .

Transfusion and Apheresis Science , vol.28, no.1, pp.9-12, 2003 (SCI-Expanded, Scopus)

187. Therapeutic plasma exchange and the clinical applications

ARSLAN Ö., Arat M., Göktürk S., Ayyildiz E., İLHAN .

Turkish Journal of Haematology , vol.20, no.1, pp.7-17, 2003 (Scopus)

188. The role of ABO incompatibility in allogeneic peripheral blood stem cell transplantation

ARSLAN Ö., Coşkun H. Ş., Arat M., SOYDAN E., ÖZCAN M., Gürman G., et al.

Turkish Journal of Haematology , vol.19, no.3, pp.401-409, 2002 (Scopus, TRDizin)

189. Extramedullary presentation of biclonal IgGκ and IgAκ multiple myeloma

Alanoǧlu G., Özet G., DALVA K., KUZU I., Erekul S., İLHAN ., et al.

Turkish Journal of Haematology , vol.19, no.3, pp.421-425, 2002 (Scopus, TRDizin)

190. Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield

DEMİRER T., İLHAN ., Ayli M., Arat M., Dagli M., ÖZCAN M., et al.

Therapeutic Apheresis , vol.6, no.5, pp.384-389, 2002 (Scopus)

191. Severity of chronic graft-versus-host disease: Association with treatment-related mortality and relapse

Lee S. J., Klein J. P., Barrett A. J., Ringden O., Antin J. H., Cahn J., et al.

Blood , vol.100, no.2, pp.406-414, 2002 (SCI-Expanded, Scopus)

192. An unusual presentation of plasma cell dyscrasias: Cardiac tamponade due to myelomatous infiltration

Arat M., Ulusoy V., DEMİRER T., Uysal A. V., ÖZCAN M., Dinçer S., et al.

Leukemia and Lymphoma , vol.43, no.1, pp.145-148, 2002 (SCI-Expanded, Scopus)

193. Influence of storage time on activation of platelets collected with CS 3000 Plus and Cobe Spectra using platelet storage containers

KUTLAY S., İLHAN ., ARSLAN Ö., Beksac M.

Therapeutic Apheresis , vol.6, no.1, pp.82-85, 2002 (Scopus)

194. In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia

Üstün C., Beksac M., DALVA K., Koc H., Konuk N., İLHAN ., et al.

Medical Oncology , vol.19, no.1, pp.59-67, 2002 (SCI-Expanded, Scopus)

195. A case of catheter related septicemia caused by Corynebacterium jeikeium

Arikan Akan Ö., Bengisun J. S., Bati A., Arat M., İLHAN ., Akan H.

Turkish Journal of Haematology , vol.19, no.1, pp.47-50, 2002 (Scopus, TRDizin)

196. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters

DEMİRER T., Dagli M., İLHAN ., Ayli M., Haznedar R., Fen T., et al.

Bone Marrow Transplantation , vol.29, no.11, pp.893-897, 2002 (SCI-Expanded, Scopus)

197. Effects of DMSO on platelet functions and P-Selectin expression during storage

Cetin M., Eser B., Er Ö., ÜNAL A., KILIÇ E., Patiroglu T., et al.

Transfusion and Apheresis Science , vol.24, no.3, pp.261-267, 2001 (SCI-Expanded, Scopus)

198. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation

Gürman G., Dilek I., ARSLAN Ö., Arat M., Beksaç M., İLHAN ., et al.

Transfusion and Apheresis Science , vol.24, no.1, pp.23-28, 2001 (SCI-Expanded, Scopus)

199. Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia: the role of ATRA.

Ustün C., Arat M., Celebi H., Akan H., İLHAN ., Ozçelik T., et al.

Haematologica , vol.86, no.10, 2001 (SCI-Expanded, Scopus)

200. CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation

DEMİRER T., İLHAN ., Arat M., YAVUZ Y., ÖZCAN M. E., DALVA K., et al.

Journal of Clinical Apheresis , vol.16, no.2, pp.67-73, 2001 (SCI-Expanded, Scopus)

201. Treatment of extensive chronic sclerodermatous graft-versus-host disease with high-dose immunosuppressive therapy and CD34+ autologous stem cell rescue [4]

Arat M., İLHAN ., Iayan E. A., Çelebl H., Koç H., Akan H.

Blood , vol.98, no.3, pp.892-893, 2001 (SCI-Expanded, Scopus)

202. Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia

Gürman G., ÇELEBİ H., Üstün C., Arat M., İLHAN ., ÖZCAN M. E., et al.

Therapeutic Apheresis , vol.5, no.1, pp.54-57, 2001 (Scopus)

203. Multiple myeloma: Current approach Multi̇pl myeloma: Güncel yaklaşimlar

Coşkun H., Er Ö., İLHAN .

Erciyes Tip Dergisi , vol.23, no.2, pp.83-90, 2001 (Scopus, TRDizin)

204. Severe hypotensive reaction due to a bedside white cell reduction filter

ARSLAN Ö., Elkiran T., Arat M., İLHAN ., Koç H.

Turkish Journal of Haematology , vol.18, no.1, pp.59-61, 2001 (Scopus, TRDizin)

205. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

ÖZCAN M. E., Üstün C., Akçağlayan E., Akan H., ARSLAN Ö., İLHAN ., et al.

Bone Marrow Transplantation , vol.27, no.5, pp.499-505, 2001 (SCI-Expanded, Scopus)

206. Treatment of aplastic anemia: Experience of Ibn-i Sina Hospital

İLHAN ., Bakanay Ş., Arat M., ÖZCAN M. E., ÇELEBİ H., Gürman G., et al.

Turkish Journal of Haematology , vol.18, no.1, pp.33-40, 2001 (Scopus, TRDizin)

207. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies

Gürman G., Arat M., İLHAN ., Konuk N., Beksaç M., ÇELEBİ H., et al.

Cytotherapy , vol.3, no.4, pp.253-260, 2001 (SCI-Expanded, Scopus)

208. Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-α-2a treatment

Beksa M., Arat M., Akan H., Ko H., İLHAN ., ÖZCAN M.

Cancer , vol.89, no.7, pp.1474-1481, 2000 (SCI-Expanded, Scopus)

209. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

DEMİRER T., İLHAN ., Mandel N., Arat M., Günel N., ÇELEBİ H., et al.

Bone Marrow Transplantation , vol.25, no.7, pp.697-703, 2000 (SCI-Expanded, Scopus)

210. Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: Experience of Ibni Sina Hospital

ARSLAN Ö., COŞKUN H., Arat M., ÇELEBİ H., ÖZCAN M. E., Gürman G., et al.

Bone Marrow Transplantation , vol.25, no.12, pp.1229-1232, 2000 (SCI-Expanded, Scopus)

211. The incidence of Hepatitis G virus in patients with hematological malignancies: The relationship to the number of blood and blood products transfusions

Idilman R., Ustun C., Aslan O., Ozcan M., Arat M., Bozkaya H., et al.

Turkish Journal of Haematology , vol.17, no.2, pp.67-71, 2000 (Scopus, TRDizin)

212. Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant G-CSF

ARSLAN Ö., Akan H., Arat M., DALVA K., ÖZCAN M. E., Gurman G., et al.

Cytotherapy , vol.2, no.4, pp.259-265, 2000 (SCI-Expanded, Scopus)

213. Immunosuppressive therapy-induced hepatotoxicity in patients with aplastic anemia

Dilek I., İDİLMAN R., Fenkci S., Ustun C., Koc H., İLHAN ., et al.

Turkish Journal of Haematology , vol.17, no.3, pp.111-117, 2000 (Scopus, TRDizin)

214. National survey of hemapheresis practice in Turkey (1998)

İLHAN ., üskent N., ARSLAN Ö., Arat M., ÖZKALEMKAŞ F., öztürk G., et al.

Transfusion and Apheresis Science , vol.22, no.3, pp.195-201, 2000 (Scopus)

215. Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations [4] (multiple letters)

Reddy V., Khan S., Wingard J., Mehta P., Marsh J., Schrezenmeier H., et al.

Blood , vol.94, no.5, pp.1833-1834, 1999 (SCI-Expanded, Scopus)

216. Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: A case report

Üstün C., Çelebi H., Arat M., ÖZCAN M., Dilek I., Gürman G., et al.

Therapeutic Apheresis , vol.3, no.3, pp.275-277, 1999 (Scopus)

217. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: A report from the European blood and marrow transplant (EBMT) severe aplastic anaemia working party

Marsh J., Schrezenmeier H., Marin R., İLHAN ., Ljungman P., McCann S., et al.

Blood , vol.93, no.7, pp.2191-2195, 1999 (SCI-Expanded, Scopus)

218. The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

İLHAN ., ARSLAN Ö., Arat M., Beksaç M., Akan H., Özean M., et al.

Transfusion Science , vol.20, no.1, pp.69-71, 1999 (SCI-Expanded, Scopus)

219. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation

DEMİRER T., ÇELEBİ H., Arat M., Üstün C., DEMİRER S., Dilek I., et al.

Bone Marrow Transplantation , vol.24, no.3, pp.335-337, 1999 (SCI-Expanded, Scopus)

220. Differences in liver pathology and clinical outcome between two patients with Hepatitis B virus and graft versus host disease

Üstün C., ÖZCAN M., Gürman G., Çakir M., Erekul S., AKYOL G., et al.

Pathology and Oncology Research , vol.5, no.3, pp.229-232, 1999 (Scopus)

221. Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe

Üstün C., İDİLMAN R., Gürman G., ÖZCAN M., AKYOL G., Akan H., et al.

Journal of Hepatology , vol.31, no.2, pp.202-209, 1999 (SCI-Expanded, Scopus)

222. Resistant graft failure overcome with allogeneic peripheral blood plus bone marrow stem cells

ARSLAN Ö., Seferoǧlu A., Gürman G., İLHAN ., Koç H.

Haematologia , vol.29, no.1, pp.47-50, 1998 (SCI-Expanded, Scopus)

223. Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey

ARSLAN Ö., Gürman G., Dilek I., ÖZCAN M., Koç H., İLHAN ., et al.

Haematologia , vol.29, no.1, pp.59-62, 1998 (SCI-Expanded, Scopus)

224. Allogeneic peripheral blood stem cell transplantation in acute non- lymphoblastic leukemia

ARSLAN Ö., Üstün C., Arat M., Çelebi H., Akan H., Beksaç M., et al.

Hematological Oncology , vol.16, no.4, pp.155-162, 1998 (SCI-Expanded, Scopus)

225. Serum erythropoietin levels in patients with leukemia on cytostatic treatment

Aydogdu I., İLHAN ., Beksac M., Koc H., Akan H., Konuk N., et al.

Haematologia , vol.29, no.2, pp.133-137, 1998 (SCI-Expanded, Scopus)

226. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia

Dilek I., DEMİRER T., Üstün C., Arat M., Koç H., Beksaç M., et al.

Bone Marrow Transplantation , vol.21, no.11, pp.1159-1161, 1998 (SCI-Expanded, Scopus)

227. Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukaemia

Beksaç M., ARSLAN Ö., Koç H., Akan H., İLHAN ., Arat M., et al.

Medical Oncology , vol.15, no.3, pp.183-190, 1998 (Scopus)

228. A case report of a patient who has pure red cell aplasia and rheumatoid arthritis

Üstün C., Karavelioǧlu D., İLHAN ., Aydintuǧ O., Beksaç M.

International Journal of Hematology , vol.66, no.4, pp.505-512, 1997 (SCI-Expanded, Scopus)

229. Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphoma

Aydogdu I., Koc H., İLHAN ., Gurman G., Akan H., Beksac M., et al.

Haematologia , vol.28, no.4, pp.207-213, 1997 (SCI-Expanded, Scopus)

230. Hepatitis B virus infection in allogeneic bone marrow transplantation

Üstün C., Koç H., Karayalçin S., AKYOL G., Gürman G., İLHAN ., et al.

Bone Marrow Transplantation , vol.20, no.4, pp.289-296, 1997 (SCI-Expanded, Scopus)

231. Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey

İLHAN ., Akan H., Koç H., Gürman G., ARSLAN Ö., ÖZCAN M. E., et al.

Hematology and Cell Therapy , vol.39, no.3, pp.133-136, 1997 (Scopus)

232. Febrile neutropenia in a bone marrow transplantation unit

Akan H., Koç H., ARSLAN Ö., Beksaç M., İLHAN ., Gürman G., et al.

International Journal of Antimicrobial Agents , vol.8, no.2, pp.127-130, 1997 (SCI-Expanded, Scopus)

233. Use of high-dose chemotherapy plus granulocyte colony-stimulating factor for the salvage of refractory or resistant-relapse lymphoma patients without stem cell support

Koç H., ARSLAN Ö., Gürman G., Akan H., ÖZCAN M., İLHAN ., et al.

Acta Haematologica , vol.98, no.3, pp.136-139, 1997 (SCI-Expanded, Scopus)

234. Hemorrhagic cystitis as a complication of bone marrow transplantation

İLHAN ., Koç H., Akan H., Gürman G., ARSLAN Ö., ÖZCAN M. E., et al.

Journal of Chemotherapy , vol.9, no.1, pp.56-61, 1997 (SCI-Expanded, Scopus)

235. Evaluation of saturation index of lymphoma patients

ÇOK İ., Karakaya A., Sardas S., İLHAN ., Koc H.

Gazi Universitesi Eczacilik Fakultesi Dergisi , vol.14, no.1, pp.5-10, 1997 (Scopus)

236. Allogeneic peripheral blood stem cell transplantation: Is there an increased risk of graft vs host disease in leukemia patients?

Koç H., Gürman G., ARSLAN Ö., ÖZCAN M. E., Dilek I., Akan H., et al.

Journal of Chemotherapy , vol.9, no.5, pp.371-376, 1997 (SCI-Expanded, Scopus)

237. Administration of mine protocol in intermediate and high grade non- Hodkin's lymphomas Primejena Protokola mine u lijecenju nehodgikinovih limfona srednjeg i visokog stupnja

Aydogdu I., Koc H., İLHAN ., Gurman G., Akan H., Beksac M., et al.

Libri Oncologici , vol.25, no.2-3, pp.103-106, 1996 (Scopus)

238. Lack of prognostic value of CD34 in adult AML.

Arslan O., Akan H., Beksac M., Ozcan M., Koc H., İLHAN ., et al.

Leukemia & lymphoma , vol.23, no.1-2, pp.185-186, 1996 (Scopus)

239. Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation? [6]

Koc H., Gurman G., ARSLAN Ö., ÖZCAN M. E., Akan H., İLHAN ., et al.

Blood , vol.88, no.6, pp.2362-2364, 1996 (Scopus)

240. A single center randomized study comparing the efficacy of sulbactam/cefoperazone + amikacin vs ceftazidim + amikacin in febrile neutropenic patients FEBRIL NOTROPENIK HASTALARDA TEK MERKEZLI RANDOMIZE BIR CALISMADA SULBAKTAM/SEFOPERAZON + AMIKASIN ILE SEFTAZIDIM + AMIKASIN ETKINLIGININ KARSILASTIRILMASI

Akan H., Koc H., Aydogdu I., İLHAN ., Beksac M., Gurman G., et al.

Mikrobiyoloji Bulteni , vol.29, no.2, pp.131-135, 1995 (Scopus, TRDizin)

241. Allogeneic peripheral blood stem cell transplantation as a second transplant for severe aplastic anemia [1]

Gurman G., Kahveci G., Akan H., İLHAN ., Koc H., Beksac M., et al.

Bone Marrow Transplantation , vol.15, no.3, pp.485-486, 1995 (Scopus)

242. HLA-DR frequency in Turkish aplastic anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapy [4]

İLHAN ., Beksac M., Koc H., Akan H., Keskin A., ARSLAN Ö., et al.

Blood , vol.86, no.5, pp.2055, 1995 (Scopus)

243. P53 codon 213 (a-g) polymorphism in a turkish population

Ilhan I., Erekul S., Ateşalp S., İLHAN ., Akar N.

Pediatric Hematology and Oncology , vol.12, no.5, pp.499-501, 1995 (Scopus)

244. Relevance of serum G-CSF levels in bone marrow transplantation patients [1]

Beksac M., ÖZCAN M. E., Koc H., Akan H., İLHAN .

Experimental Hematology , vol.22, no.6, pp.480-481, 1994 (Scopus)

245. Terminal deoxynucleotidyl transferase (TdT) positivity in acute nonlymphoblastic leukemia [1]

ARSLAN Ö., Akan H., Beksac M., İLHAN ., Koc H., Konuk N.

Leukemia , vol.8, no.6, pp.1067, 1994 (Scopus)

246. Peripheral T cell receptors αβ, and γδ in patients with Hodgkin's lymphoma

Akan H., Beksac M., Aydogdu I., Koc H., İLHAN ., Ozcan M.

British Journal of Haematology , vol.87, no.3, pp.544-547, 1994 (Scopus)

247. Cyclosporin A (CsA) + methylprednisone (MP) and antilymphocyte globulin + methylprednisone (MP) therapy in patients with aplastic anemia: Ibn-i Sina Hospital experience

İLHAN ., Koc H., Beksac M., Akan H., Aydogdu I., Konuk N., et al.

Bulletin of Gulhane Military Medical Academy , vol.35, no.4, pp.893-897, 1993 (Scopus)

248. The clinical correlations of serum tumor necrosis factor-alpha in acute leukemias: A predictor of response and relapse?

Beksaç M., ERTÜRK Ş., Akan H., Koç H., İLHAN .

Leukemia , vol.7, no.11, pp.1773-1776, 1993 (Scopus)

249. Circulating endogenous granulocyte colony-stimulating factor levels after bone marrow transplantation [4]

Beksac M., ÖZCAN M. E., Koc H., Akan H., İLHAN ., Sardas O., et al.

Blood , vol.80, no.11, pp.2946-2947, 1992 (Scopus)

250. Use of high dose chemotherapy and autologous bone marrow transplantation in patients with intermediate or high grade NHL both as a consolidation after remission or in early relapse

Sardas O., Koc H., İLHAN ., Akan H., Beksac M.

Istanbul Tip Fakultesi Mecmuasi , vol.54, no.4, pp.567-574, 1991 (Scopus)

251. Hepatic failure after bone marrow transplantation (I)

Sardas O., Koc H., İLHAN ., Akan H., Beksac M.

Blood , vol.75, no.11, pp.2265, 1990 (Scopus)

252. Polymorphic N‐acetylation capacity in breast cancer patients

Şardş S., ÇOK İ., Seyfişardaş O., İLHAN ., Karakaya A. E.

International Journal of Cancer , vol.46, no.6, pp.1138-1139, 1990 (Scopus)

253. Tumor necrosis factor α in human bone marrow recipients

Sardas O., Beksac M., Koc H., İLHAN ., Akan H., Gurman G.

Blood , vol.76, no.12, pp.2639, 1990 (Scopus)

254. A meningococcal epidemic in Ankara Ankara ilinde devam etmekte olan menengokoksk menenjit salgini.

Berkman E., Ozben G., İLHAN .

Mikrobiyoloji Bulteni , vol.11, no.2, pp.256-266, 1977 (Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 174

1. the impact of pretransplant ımmunomodulatory drugs on cmv reactıvatıon

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., YAVUZ G., et al.

8th International Congress on Leukemia Lymphoma Myeloma, 10 January 2021, (Full Text)

2. PATIENT RELATED FACTORS OVERRIDE LENALIDOMIDE MAINTENANCE AS A FACTOR OF SEVERITY FOR COVID-19 INFECTION

KIRCALI E., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

8th International Congress on Leukemia Lymphoma Myeloma, 21 May 2021, (Full Text)

3. TİROZİN KİNAZ İNHİBİTÖRLERİNİ KESME KARARINDA KEMİKİLİĞİNDEKİ LÖSEMİK KÖK HÜCRE VARLIĞININ ÖNEMİ

İLHAN O., NARLI ÖZDEMİR Z., ARSLAN A., OKAY M., İPEK Ş., DALVA K., et al.

46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, (Summary Text)

4. DECISION TO STOP TYROSINE KINASE INHIBITORS (TKIS) WITH BONE MARROW LEUKEMIC STEM CELL LEVEL: DETECTION OF BCR-ABL IN PERIPHERAL BLOOD MAY NOT BE ENOUGH

İLHAN O., NARLI ÖZDEMİR Z., ARSLAN A., OKAY M., İPEK Ş., DALVA K., et al.

25th European Hematology Congress Virtual, 11 - 21 June 2020, (Summary Text)

5. Allogeneic hematopoietic stem cell transplantation for primary myelofibrosis: A single-center experience

DEMİRER T., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

2020 American Society of Clinical Oncology (ASCO) Annual Meeting, 29 May - 02 June 2020, vol.38, pp.19522, (Full Text)

6. A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm

ÖZCAN M., KOYUN D., CENGİZ SEVAL G., USLU A., KIRCALİ E., ÖZTÜRK C., et al.

2020 American Society of Clinical Oncology (ASCO) Annual Meeting, 29 May - 02 June 2020, (Full Text)

7. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

CENGİZ SEVAL G., Öztürk N., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Orlando, United States Of America, 19 - 23 February 2020, vol.26, pp.109-110, (Full Text)

8. Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease

İLHAN O., Seval G. C., UZAY A., KAYA E., Öztürk Z. N., DEVECİ B., et al.

Transplantation Cellular Therapy Meetings of ASTCT and CIBMTR, United States Of America, 8 - 12 February 2020, vol.26, pp.191, (Full Text)

9. Assessment of Longer-Term Efficacy and Safety in the Phase 3, Randomized, Double-Blind, Placebo-Controlled MEDALIST Trial of Luspatercept to Treat Anemia in Patients (Pts) with Revised International Prognostic Scoring System (IPSS-R) Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Pierre F., Ghulam J. M., Rena J B., Valeria S., Mara Dez C., Carlo F., et al.

ASH 2019, 7 - 10 December 2019

10. Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

CENGİZ SEVAL G., USLU A., KIRCALI E., CİVRİZ BOZDAĞ S., DALVA K., TOPRAK S. K., et al.

ASH 2019, 7 - 10 December 2019, (Summary Text)

11. Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

KIRCALI E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.

ASH 2019, 7 - 10 December 2019, (Summary Text)

12. Obinutuzumab Alone or Combined with Chemotherapy in Previously Untreated (Fit or Unfit) or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients: Final Results from the Phase IIIb GREEN Safety Study with a Focus on Efficacy

Stephan S., Bosch F., Vronique L., İLHAN O., Jens K., Batrice M., et al.

ASH 2019, 7 - 10 December 2019, (Full Text)

13. Hematologic Improvement–Neutrophil and –Platelet in the MEDALIST Trial: Multilineage Data from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Guillermo G., hulam J. M., Pierre F., Valeria S., Mara Dez C., Carlo F., et al.

ASH2019, 7 - 10 December 2019, (Full Text)

14. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

CENGİZ SEVAL G., ÖZTÜRK N., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

ASH 2019, 7 - 10 December 2019, (Summary Text)

15. KRONİK MİYELOİD LOSEMİ (KML) HASTALARINDA KML KOKHUCRESİ BCR- ABL’DEN BAĞIMSIZ PROGNOSTİK BİR FAKTOR OLABİLİR Mİ?

TOPRAK S. K., güven m., CENGİZ SEVAL G., DALVA K., İpek Ş., Okul N., et al.

45. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 30 October - 02 November 2019, (Summary Text)

16. YENİ TANI KLL HASTALARINDA TANI SIRASINDAKİ CD49DEKSPRESYONUNUN HASTALIĞA OZGU BAŞKA PARAMETRELERLEİLİŞKİSİ

TOPRAK S. K., güven m., CENGİZ SEVAL G., DALVA K., İpek Ş., Okul N., et al.

45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, (Full Text)

17. Kronik Myeloid Lösemi (KML) Hastalarında KML Kök Hücresi BCR-ABL’ den Bağımsız Prognostik Bir Faktör Olabilir mi?

İLHAN O., NARLI ÖZDEMİR Z., ARSLAN A., OKAY M., İPEK Ş., DALVA K., et al.

45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, (Summary Text)

18. YAŞAM SÜRESİNİ VE KALİTESİNİ ETKİLEYEN DİRENÇLİ KGVHH TEDAVİSİNDE YENİ BİR YAKLAŞIMBTK İNHİBİTÖRÜ:GERÇEK YAŞAM VERİSİ

İLHAN O., Seval G. C., UZAY A., KAYA E., DEVECİ B., YAVAŞOĞLU İ., et al.

45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, (Full Text)

19. TÜRKİYE’DE PAROKSİSMAL NOKTÜRNAL HEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARIN ÇOKMERKEZLİ TANISAL TARAMA ÇALIŞMASI

İLHAN O., ÖZDEMİR Z. N., ÖZET G., FALAY M., YENEREL M. N., TUĞLULAR A. T., et al.

45. Ulusal Hematoloji Kongresi, Antalya, Turkey, 30 October - 02 November 2019, pp.131-132, (Full Text)

20. TÜRKİYE’DE PAROKSİSMAL NOKTÜRNALHEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARIN ÇOKMERKEZLİ TANISAL TARAMA ÇALIŞMASI

İLHAN O., NARLI ÖZDEMİR Z., ÖZET G., falay m., YENEREL M. N., TUĞLULAR A. T., et al.

45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, (Summary Text)

21. A retrospective single center experience with the generic of lenalidomide Rivelime (R) compared with original patented drug Revlimid (R)

BEKSAÇ M., CENGİZ SEVAL G., KOYUN D., TOPÇUOĞLU P., YÜKSEL M., GÜRMAN G., et al.

Lymphoma and Myeloma Congress 2019, 23 - 26 October 2019, (Full Text)

22. Negative Impact of High LDH at Diagnosis on OS, But Not PFS, Can Be Overcome by Autologous Stem Cell Transplantation

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

17th International Myeloma Workshop, 12 - 15 September 2019, (Full Text)

23. Haploidentical stem cell transplantation may be an option for hematological malignancies in urgent conditions

İLHAN O., CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

45th Annual Meeting of the European Society for Blood and Marrow Transplantation, 24 - 27 March 2019, (Full Text)

24. Clonal Plasma Cell Detection by High Sensitive Flow Cytometry in Aphaeresis Product is Poor Prognostıc and not Increased by Use of Plerixafor Alone

CENGİZ SEVAL G., USLU A., DALVA K., BAKANAY S., MERTER M., ŞAHİN U., et al.

45th Annual Meeting of the European Society for Blood and Marrow Transplantation, Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.496-497, (Summary Text)

25. Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT

YÜKSEL M., CENGİZ SEVAL G., KİRCİLİ E., D, K., ÖZTÜRK C., NARLI ÖZDEMİR Z., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), 24 - 27 March 2019, (Full Text)

26. Is mobilization with chemotherapy effect response in the multiple myeloma?

CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., ÖZCAN M., et al.

45th Annual Meeting of the European Society for Blood and Marrow Transplantation, 24 - 27 March 2019, (Full Text)

27. Can Nelarabıne Rescue The Graft After Allogeneıc Hematopoıetıc Stem Cell Transplantatıon In T-All ?

YÜKSEL M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

24th Congress of the European Hematology Association, 13 - 16 June 2019, (Full Text)

28. Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?

İLHAN O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

2019 American Society of Clinical Oncology (ASCO) Annual Meeting, 1 - 03 June 2019, (Full Text)

29. Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation

DEMİRER T., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

2019 American Society of Clinical Oncology (ASCO) Annual Meeting, 1 - 03 June 2019, (Full Text)

30. Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.

DEMİRER T., SEVAL G. C., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

ASCO, 31 May - 03 June 2019, (Full Text)

31. RETROSPECTIVE ANALYSIS OF 149 UNSELECTED PATIENTS WITH MANTLE CELL LYMPHOMA CONFIRMS PROGNOSTIC RELEVANCE OF MIPI: SINGLE CENTER EXPERIENCE

CENGİZ SEVAL G., ULAŞ B. B., Bolat B., Taşçı O., Karatepe F., KUZU I., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 May 2019, (Full Text)

32. LEUKAPHERESIS REDUCES 4-WEEK MORTALITY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS - A RETROSPECTIVE STUDY FROM A TERTIARY CENTER

CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 May 2019, (Full Text)

33. PRE-TRANSPLANT HEMOGLOBIN AND SERUM CREATININE LEVELS CORRELATE WITH PROGRESSION FREE SURVIVAL IN MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 May 2019, (Full Text)

34. CAN ELTROMBOPAG TREAT THE THROMBCYTOPENIA AFTER STEM CELL TRANSPLANTATION

YÜKSEL M., KIRCALI E., CENGİZ SEVAL G., KOYUN D., USLU A., ÖZTÜRK C., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 May 2019, (Summary Text)

35. LEUKAPHERESIS REDUCES 4-WEEK MORTALITY IN ACUTEMYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS -A RETROSPECTIVE STUDY FROM A TERTIARY CENTER

SEVAL G. C., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 May 2019, (Full Text)

36. CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGHLDH?

SEVAL G. C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 May 2019, (Full Text)

37. retrospective analysis of 149 unselected patıents wıth mantle cell lymphoma confırms prognostic relevance of mıpı: sıngle center ecperıence

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

ICLLM 2019, 02 May 2019, (Full Text)

38. RETROSPECTIVE ANALYSIS OF 149 UNSELECTED PATIENTSWITH MANTLE CELL LYMPHOMA CONFIRMS PROGNOSTICRELEVANCE OF MIPI: SINGLE CENTER EXPERIENCE

SEVAL G. C., ULAŞ B. B., bolat b., Taşçı O., karatepe f., KUZU I., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 May 2019, (Full Text)

39. Transplant Sonrası Trombositopenide Eltrombopag: Tek Merkez Deneyimimiz

KIRCALİ E., CENGİZ SEVAL G., KOYUN D., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., ÖZCAN M., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2019, (Summary Text)

40. Multiple Myelom Hastalarında Otolog Periferik Kök Hücre Nakli Esnasında Gelişen Nötropenik Ateş

USLU A., CENGİZ SEVAL G., ÖZTÜRK C., NARLI ÖZDEMİR Z., KIRCALİ E., KOYUN D., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2019, (Summary Text)

41. Allojeneik Kök Hücre Nakli Sonrası Akut Lösemi Hastalarında Nüksü Öngörmede Kimerizm İle Mrd Karşılaştırılması

CENGİZ SEVAL G., ULAŞ B. B., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2019, (Summary Text)

42. İyi Riskli Aml’de İkinci Tam Remisyonda Allojeneik Hematopoietik Kök Hücre Nakli Tek Merkez Deneyimi

PEKCAN G., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2019, (Summary Text)

43. POSTTRANSPLANT LENFOSİTOZ ÖNEMLİ BİR PARAMETRE MİDİR?

CENGİZ SEVAL G., USLU A., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2019, (Full Text)

44. T-All Hastalarında Allojeneik Hematopoetik Kök Hücre Nakli Sonrasında Nelarabin Tedavisi Graftı Kurtarabilir mi?

CENGİZ SEVAL G., USLU A., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2019, (Summary Text)

45. Refrakter Akut Lösemili Hastalarda Ardışık Kurtarma Tedavisi İle Birlikte Ahkhn Yeterli Kür Sağlayabilir mi?

CENGİZ SEVAL G., KIRCALİ E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2019, (Summary Text)

46. Plerixafor, Periferik Kök Hücre Ürününde Akım Sitometri İle Saptanabilen Klonal Plazma Hücre Kontaminasyonunu Etkiler Mi?

CENGİZ SEVAL G., USLU A., DALVA K., BAKANAY ÖZTÜRK Ş. M., MERTER M., ŞAHİN U., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 02 March 2019, pp.74-75, (Summary Text)

47. Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.

ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 February 2019, (Full Text)

48. Akut Miyeloid Lösemide Nakil Öncesi Minimal Kalıntı Hastalık Diğer Risk Faktörlerinden Daha Önemli Midir?

NARLI ÖZDEMİR Z., ŞAHİN U., BALTACI M. A., USLU A., ÖZTÜRK C., CENGİZ SEVAL G., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 02 March 2019, pp.76-77, (Summary Text)

49. Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.

ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 February 2019, vol.25, pp.322, (Full Text)

50. Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.

ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 February 2019, (Full Text)

51. MİYELOM HASTALARINDA OHKHN ÖNCESİ KULLANILAN İLAÇLARIN CMV REAKTİVASYONU ÜZERİNE SAĞKALIMI AZALTICI ETKİSİ OLABİLİR Mİ?

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., ÖZTÜRK C., et al.

11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2019, (Full Text)

52. CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGH LDH?

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 May 2019, (Full Text)

53. Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.

ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 February 2019, (Full Text)

54. Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.

ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 February 2019, (Full Text)

55. Influence of Conditioning Regimens with Total Body Irradiation (TBI) on Graft Versus Host Disease and Graft Versus Leukemia Effect Following Donor Lymphocyte Infusions (DLI)

SEVAL G. C., ATİLLA E., ULAŞ B. B., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 20 - 24 February 2019, vol.25, pp.176-177, (Full Text)

56. İmmun Trombositopeni (İTP) hastalarında ABO kan gruplarının birinci basamak tedavi yanıtına etkisi

AKKUŞ E., FİDAN Ç., KUŞTAŞ A. A., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

TKBD Uluslararası Katılımlı Hematolojik Hastalıkların Tanı Ve İzleminde Laboratuvar Sempozyumu, Turkey, 5 - 07 April 2018, vol.16, pp.44, (Summary Text)

57. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF

DEMİRER T., AYLI M., ÖZCAN M., GÜNEL N., HAZNEDAR R., DAĞLI M., et al.

BRITISH JOURNAL OF HAEMATOLOGY, 1 January - 30 December 2018, vol.116, pp.468-474, (Summary Text)

58. Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

SEVAL G. C., ULAŞ B. B., Taşçı O., Özel F., Bulat B., KUZU I., et al.

60th ASH Annual Meeting, San Diego, United States Of America, 30 November - 05 December 2018, (Full Text)

59. Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

TOPÇUOĞLU P., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DALVA K., et al.

60th ASH Annual Meeting, san diego, United States Of America, 29 November - 05 December 2018, vol.132, pp.5776, (Full Text)

60. Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

GÜRMAN G., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

60th ASH Annual Meeting Exposition, san Diego, 29 November - 04 December 2018, vol.132, pp.4673, (Full Text)

61. Residual Clonal Plasma Cells Detected by Flow Cytometry at 10-4 Level within Autologous Stem Cell Grafts is Associated with Significantly Less Overall Survival

CENGİZ SEVAL G., DALVA K., BAKANAY S., MERTER M., ŞAHİN U., USLU A., et al.

60th American Society of Hematology Annual Meeting, San Diego, CA, United States Of America, 1 - 04 December 2018, vol.132, pp.3438, (Summary Text)

62. Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

ATİLLA E., TOPÇUOĞLU P., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., DEMİRER T., et al.

60th ASH Annual Meeting, 30 November - 05 December 2018, (Summary Text)

63. The Outcome of Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Isolated CD4(+) T-cell Deficiency with Interleukin-2 Inducible T-cell Kinase (ITK) Gene Defect

YÜKSEL M., NARLI ÖZDEMİR Z., ŞAHİN U., ÇAĞDAŞ AYVAZ D. N., TURKUM ATIKCAN D., SERTESEN E., et al.

44th Annual Meeting of European Society for Blood and Marrow Transplantation, Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.533-534, (Summary Text)

64. İndüksiyon Mu Hazırlama Rejimi Mi Daha Önemli? İndüksiyon Sonrası Kalıntı Hastalığın Saptanamaması Bir Prognostik Gösterge Olabilir

CENGİZ SEVAL G., BAKANAY ÖZTÜRK Ş. M., MERTER M., ŞAHİN U., USLU A., NARLI ÖZDEMİR Z., et al.

44. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2018, pp.161-162, (Full Text)

65. Hematopoietik kök hücre nakli için toplanan kemik iliği materyallerinde sayılan cd34 pozitif hücreler: Cd34 pozitif gen hematogonlara dikkat

DALVA K., Öz m. d., hakkoloğlu ş., avcu f., ERTEM M., İLHAN O., et al.

44. ulusal hematoloji kongresi, Turkey, 31 October - 03 November 2018, (Full Text)

66. ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN ALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİL SONUÇLARINA ETKİLERİ

KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.

44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, (Full Text)

67. Hematopoietik kök hücre nakli için toplanan kemik iliği materyallerinde sayılan Cd34 pozitif hücreler: CD34pozitif genç hematogonlara dikkat

DALVA K., Öz m. d., hakkoloğlu ş., ipek ş., öztürk a., taşkır f., et al.

44. ulusal hematoloji kongresi, Turkey, 31 October - 03 November 2018, (Summary Text)

68. ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN ALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİLSONUÇLARINA ETKİLERİ

KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.

44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, (Summary Text)

69. Promising utilization areas of theurapeutic plasmapheresis in cardiovascular surgery practice

DURDU M. S., ÇAKICI M., GÜMÜŞ F., ÇUBUKÇUOĞLU DENİZ G., CİVRİZ BOZDAĞ S., DİKMEN YAMAN N., et al.

Türk Kalp ve Damar Cerrahisi Derneği 15. Kongresi, Turkey, 26 - 29 October 2018, vol.26, (Full Text)

70. Yüksek PRA Düzeyi Olan Böbrek Nakli Alıcılarında Plazmaferez , IVIG ve Ritüksimab Tedavisinin Etkinliği

ORS SENDOGAN D., SARITAŞ H., KUMRU G., İLHAN O., TÜZÜNER A., KEVEN K., et al.

Ulusan Nefroloji, Hipertansiyon, Diyaliz ve tRansplantasyon Kongresi, Antalya, Turkey, 3 - 07 October 2018, (Summary Text)

71. AKUT LÖSEMİ HASTALARINDA HLA UYUŞUMSUZLUĞUNUN NAKİL SONUÇLARINA ETKİSİ: TEK MERKEZ DENEYİMİ

CENGİZ SEVAL G., NARLI ÖZDEMİR Z., TATAR L., SÖKMEN M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, (Full Text)

72. Retrospective analysis of 115 unselected patients with mantle cell lymphoma: Single center experience

Cengiz Seval G., BULAT B., Ozel F., Tasci O., Kuzu I., CİVRİZ BOZDAĞ S., et al.

ASCO Annual Meeting 2018, 1 - 05 June 2018, vol.36, pp.19525, (Full Text)

73. Akut karaciğer yetmezliğinde plazmaferezin etkinliği

SANDAL S., ZEYBEK İ., TUNA KIRSAÇLIOĞLU C., ALTUNTAŞ C., DEMİR E., KENDİRLİ T., et al.

12.Ulusal Çocuk Gastroenteroloji, Hepatoloji ve BESLENME kONGRESİ, Turkey, 18 - 21 April 2018, (Summary Text)

74. Heparin enhances CD34 content of stem cells collected following G-CSF +/- chemotherapy

MERTER M., ŞAHİN U., YILDIRIM Y., İLHAN O., BEKSAÇ M.

44th Annual Meeting of European Society for Blood and Marrow Transplantation, Lizbon, Portugal, 18 - 21 March 2018, (Summary Text)

75. Fit Elderly Patients with aggressive lymphoma do not need dose reduction of conditioning regimen

İLHAN O., CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

44th Annual Meeting of the European Society for Blood and Marrow Transplantation, 18 - 21 March 2018, (Full Text)

76. Impact of Hepatitis B Core Antibody Seopositivity on the Liver Function Tests after Autologous Hematopoietic Stem Cell Transplantation For Multiple Myeloma

CENGİZ SEVAL G., SERTESEN E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

44th Annual Meeting of the European Society for Blood and Marrow Transplantation, 18 - 21 March 2018, (Full Text)

77. BlastIc Plasmacyto Id DendrItIc Cell Neoplasm: SIngle CenterExperIence on a Rare Hematological Malignancy

NARLI ÖZDEMİR Z., SEVAL G. C., USLU A., GÜNDÜZ M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

5th Aegean Hematology Oncology Symphosium, Greece, 23 September 2018, (Summary Text)

78. Donor lymphocyte infusion after salvage chemotherapy inrelapsed acute myeloblastic leukemia patients afterallogeneic stem cell transplantation

USLU A., SEVAL G. C., CİVRİZ BOZDAĞ S., GÜRMAN G., DEMİRER T., ARSLAN Ö., et al.

The 44th Annual Meeting of the European Society for Blood andMarrow Transplantation: Physicians Poster Sessions, lizbon, Portugal, 18 - 21 March 2018, (Full Text)

79. ALLOJENEİK KÖK HÜCRE NAKLİ SONRASI GELİŞENKARACİĞER SİNÜZOİDAL TIKANIKLIK SENDROM İNSİDANSIVE KLİNİK BULGULAR

GÜNDÜZ M., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.

10. ULUSAL KEMİK İLİĞİTRANSPLANTASYONU VEHÜCRESEL TEDAVİLER KONGRESİ, Antalya, Turkey, 1 - 03 March 2018, (Summary Text)

80. Allojeneik Hematopoetik Kök Hücre Nakli Sonrası Akut Myeloid Lösemi Nüksünün Yönetimi ve Prognozu

ŞAHİN U., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., ÖZEN M., CİVRİZ BOZDAĞ S., et al.

10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 03 March 2018, pp.126-127, (Summary Text)

81. Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

ARSLAN Ö., ELÇİN A. E., ATİLLA E., Şeker Ş., Baydın P., Gündüz M., et al.

ASBMT 2018, 21 - 25 February 2018, vol.24, pp.152-153, (Summary Text)

82. Ph Negatif ALL’de 1. Tam Remisyonda Yapılan Pekiştirme Tedavileri Nakil Sonrası Başarıyı Arttırır

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 03 March 2018, pp.107-108, (Summary Text)

83. Age is Not an Important Factor for Autologous Peripheral Hematopoietic Stem Cell Mobilization and Collection in Patients with Multiple Myeloma

İLHAN O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

2018 BMT Tandem Meetings, 21 - 25 February 2018, vol.24, pp.140, (Full Text)

84. Retrospective Analysis Learn Conditioning for Autologous Stem Cell Transplantation

SOYDAN E., GÖKMEN A., İLHAN O., ARSLAN Ö., ÖZCAN M.

Blood @marrow translant Res, 21 - 25 February 2018, (Summary Text)

85. Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

ATİLLA E., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., AKAN H., et al.

American Society of Hematology, 8 - 12 December 2017, (Summary Text)

86. Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma

İLHAN O., Güldane C., TOPRAK S. K., TOPÇUOĞLU P., Özel F., CİVRİZ BOZDAĞ S., et al.

American Society of Hematology, 8 - 12 December 2017, (Summary Text)

87. Hematolojik Maligniteli Hastalarda Haploidentik Kök Hücre Nakillerinde Mezenkimal Kök Hücre Uygulaması

ARSLAN Ö., ELÇİN A. E., ATİLLA E., ŞEKER Ş., BAYDIN P., GÜNDÜZ M., et al.

43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, (Summary Text)

88. Hematolojik Maligniteli Hastalarda Haploidentik Kök Hücre Nakillerinde Mezenkimal Kök Hücre Uygulaması.

ARSLAN Ö., ELÇİN A. E., ATİLLA E., ŞEKER Ş., BAYDIN P., GÜNDÜZ M., et al.

43.ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 1 - 04 November 2017, (Summary Text)

89. Engrafmanın Erken Belirteci: Büyük Boyanmamış Hücreler

Aydın T., MERTER M., ŞAHİN U., Pekcan G., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.

43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.53, (Summary Text)

90. İmmun Trombositopenide (İTP) Yenilikler Işığında Klinik Retrospektif Değerlendirme: Tek Merkez Deneyimi

AKKUŞ E., KUŞTAŞ A. A., PEKCAN G., MERTER M., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.

43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.98-99, (Summary Text)

91. OTOLOG PERİFERİK KÖK HÜCRE NAKLİNDE KÖK HÜCRESAKLANMA SÜRESİ ENGRAFMAN SÜRESİNİ ETKİLER Mİ?

MERTER M., Güleç B., Özcan G., Zehra Özdemir Z., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.220, (Summary Text)

92. TÜRKİYE’DE PAROKSİSMAL NOKTÜRNALHEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARINSIKLIĞININ SAPTANMASINA YÖNELİK ÇALIŞMA

İLHAN O., ÖZET G., FALAY M., YENEREL M. N., TURGUT M., ÜNAL A., et al.

43. Ulusal Hematoloji Kongresi, Turkey, 1 - 05 November 2017, (Full Text)

93. Türkiye’den Çok Merkezli Erken Erişim Program Sonuçları: Daha Önce Yoğun Tedavi Almış Relaps/Refrakter Multipl Miyelom Hastalarında Daratumumabın Etkililik ve Güvenliliği

BEKSAÇ M., GOKER H., TURGUT M., AYDIN Y., BESİSİK S., Cagirgan S., et al.

Türk Hematoloji Derneği, Turkey, 17 - 20 August 2017, (Summary Text)

94. Evaluating peritransplant albumin decline as a predictor of acute graft versus host disease

MERTER M., YÜKSEL M., demir e., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., et al.

43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, Marseille, France, 26 - 29 March 2017, vol.52, pp.210-211, (Summary Text)

95. The outcome of haploidentical hematopoietic celltransplantations

ATİLLA E., bilgiç e., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 March 2017, vol.52, pp.314, (Summary Text)

96. Peripheral blood stem cell mobilization and collectionfrom elderly patients (≥65 years) with multiple myeloma: Asingle center experience

seval g. c., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 March 2017, vol.52, (Summary Text)

97. peripheral blood stem cell mobilization and collection from elderly patients with multiple myeloma:A single center experience

seval g., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

ebmt 2017, 26 - 29 March 2017, (Summary Text)

98. Allogeneic hematopoietic stem cell transplantation(allo-HSCT) in advanced age adults: is it possible totransplant safely?

ATİLLA E., baŞ o., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 March 2017, vol.52, pp.272-273, (Summary Text)

99. ALLOEGENEİC HEMATOPOİETİC STEM CELL TRANSPLANTATİON İN ADVANCED AGE ADULTS:İS İT POSSİBLE TO TRANSPLANT SAFELY?

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., AKAN H., et al.

ebmt2017, 26 - 29 March 2017, (Summary Text)

100. The outcome of haploidentical stem cell transplantation

ATİLLA E., bilgiç e., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

ebmt 2017, 22 - 25 June 2017, (Summary Text)

101. AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA: SINGLE CENTER EXPERIENCE

TOPRAK S. K., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

22nd Congress of the European-Hematology-Association, 22 - 25 June 2017, (Summary Text)

102. Autologous Stem Cell Trnasplantation for Mantle Cell Lymphoma: A Single Center Exprience

TOPRAK S. K., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

Exprience22nd Congress of the European Hematolgy Association, 22 June - 25 May 2017, (Summary Text)

103. A single center experience with two decades of follow-up on patients with hairy cell leukemia.

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2 - 06 June 2017, (Summary Text)

104. Age as a decision factor for doing autologous stem cell transplantation in fit patients with myeloma and lymphoma

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

53rd Annual Meeting, 2 - 06 June 2017, (Summary Text)

105. Comparison of myeloablative vs reduced intensity conditioning regimens in stem cell transplantationd for acute myeloid leukemia

GÜRMAN G., AYDEMİR GULOKSUZ G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

leukemia53rd Annual Meeting, 2 - 06 June 2017, (Summary Text)

106. Allojeneik stem cell transplantation results in our myelodysplastic sydrome (MDS) patientes

GÜRMAN G., ATACA ATİLLA P., AYDIN T., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

patientes53rd Annual Meeting Jun 2-6, 2017, 2 - 06 June 2017, (Summary Text)

107. A single center experience With two decades of follow-up on patients With hairy cell leukemia

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

3rd Annual Meeting Jun 2-6, 2017, 2 - 06 June 2017, (Summary Text)

108. Large Unstained Cell Percentage as a Predictor of Efficacious Peripheral Stem Cell Mobilization

MERTER M., KÖKEN K., YÜKSEL M., NURDAN DEMİR E., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.

6th International Congress on Leukemia Lymphoma Myeloma, 11 - 13 May 2017, (Summary Text)

109. A biosimilar G-CSF filgrastim is as effective as a reference drug, however, it is not as cost effective as it supposed to be

PEKCAN G., KURT YÜKSEL M., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

6th International Congress on Leukemia Lymphoma Myeloma, Antalya, Turkey, 11 - 13 May 2017, pp.112, (Summary Text)

110. Evalauting peritransplant albümin decline as a predictor os acute graft versus host disease

MERTER M., YÜKSEL M., NURDAN DEMİR E., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., et al.

43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 March 2017, (Summary Text)

111. Allegeneic Hematopoetic Stem Cell Trnasplantation (Allo-HSCT) in advanced age adults:Is it possible to transplant safely?

ATİLLA E., BAŞ Ö., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

43rd Annual Meeting Of EBMT, 26 - 29 March 2017, (Summary Text)

112. Large Unsatained Cell (LUC) percentage as a predictor of efficacious peripheral stem cell mobilization in autologous stem cell transplantation

MERTER M., KÖKEN K., YÜKSEL M., DEMİR N., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.

43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 March 2017, (Summary Text)

113. Herpes SimplexVirus infection in patients after allogeneic hematopoetic stem cell transplantation

ATİLLA E., ÖZEL F., YILMAZ V., ATACA ATİLLA P., ATEŞAĞAOĞLU B., CİVRİZ BOZDAĞ S., et al.

43rd Annual Meeting Of EBMT, 26 - 29 March 2017, (Summary Text)

114. Peripheral Blood Stem Cell Mobilization and collection from elderly patients 65 years with multipl myeloma: A , single center exprience

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

43rd Annual Meeting Of EBMT, 26 - 29 March 2017, (Summary Text)

115. The outcome of Haploidentical Hematopoietic Celll Trnasplantations (Haplo HSCT)

ATİLLA E., ECE B., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

43rd Annual Meeting Of EBMT, 26 - 29 March 2017, (Summary Text)

116. Acute GVHD and unreated/haploidentical Trnasplants incrreses the incidence of hemorrhagic cystitis in Allo- HSCT Recipients

TOPÇUOĞLU P., ATİLLA E., ATACA ATİLLA P., USLU A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

43rd Annual Meeting Of EBMT, 26 - 29 March 2017, (Summary Text)

117. Management and Outcome of Central Nerve System(CNS) Involvement in Acute Lymphoblastic Leukemia

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

BMT Tandem Meetings, orlando, United States Of America, 22 - 26 February 2017, vol.23, pp.251, (Summary Text)

118. Management and Outcome of Central Nervous System (CNS) Involvement in Acute Lymphoblastic Leukemia (ALL)

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

BMT Tandem Meetings, 22 - 26 February 2017, (Summary Text)

119. Catheter Thrombosis in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Recipients

GÜRMAN G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

BMT Tandem Meetings, 22 - 26 February 2017, (Summary Text)

120. Allogeneic stem cell transplantation for chonic lymphocytic Leukemai

ATİLLA E., ATACA ATİLLA P., pekcan g., İLHAN O., GÜRMAN G., ÖZCAN M., et al.

BMT TANDEM MEETINGS, 22 - 26 February 2017, (Summary Text)

121. Does Hypogammaglobulinemia at Diagosis Effects Survival and Infection Risk in Chronic Lymphocytic Leukemia CLL

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., İLHAN O., et al.

ASH, 3 - 06 December 2016, (Summary Text)

122. Comparison of Reduced Intensity Conditioning RIC Regimen and Myeloablative Conditioning MAC Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Allo HSCT for Adult Patients with Acute Leukemia

GÜRMAN G., AYDEMİR GÜLÖKSÜZ G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

ASH, 3 - 06 December 2016, (Summary Text)

123. AKUT MYELOİD LÖSEMİDE FLOW SİTOMETRİ İLEİNDÜKSİYON SONRASI TESPİT EDİLEN CD34 HÜCRESAYISI SAĞKALIM VE RELAPSI ETKİLER

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., TOPRAK S. K., et al.

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

124. ALLOJENEİK KÖK HÜCRE NAKLİ OLAN AKUTLÖSEMİLERDE HAZIRLIK REJİMLERİNİNKARŞILAŞTIRILMASI

GÜLÖKSÜZ G. A., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

125. KRONİK LENFOSİTİK LÖSEMİ DE TANI ANINDAHİPOGAMAGLOBULİNEMİ SAĞKALIM VE ENFEKSİYONRİSKİ ÜZERİNDE ETKİLİ MİDİR

ATACA ATİLLA P., ATİLLA E., PEKCAN G., TOPRAK S. K., TOPÇUOĞLU P., AKAN H., et al.

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

126. ALLOJENEİK KÖK HÜCRE NAKLİ YAPILANHASTALARDA PERİTRANSPLANT ALBUMİN DÜŞÜŞÜİLE GVHD İLİŞKİSİ

MERTER M., Şah F. T., ŞAHİN U., YALÇINER M., Kocabay H. E., CİVRİZ BOZDAĞ S., et al.

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

127. TROMBOTİK MİKROANJİOPATİDE TERAPÖTİKPLAZMA DEĞİŞİMİ

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., TOPÇUOĞLU P., YÜKSEL M., CİVRİZ BOZDAĞ S., et al.

42. Ulusal Hematoloji, Turkey, 19 - 22 October 2016

128. MYELODİSPLASTİK SENDROM HASTALARININOGATA SKORLAMASI İLE FLOW SİTOMETRİKOLARAK DEĞERLENDİRİLMESİ

ATİLLA E., ATACA ATİLLA P., TÜREDİ Ö., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

42.Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

129. GRAFT VERSUS HOST HASTALIĞINDAEKSTRAKORPOREAL FOTOFEREZİN YERİ

GÜNDÜZ M., ATİLLA E., ATACA ATİLLA P., AKAY B. N., ŞANLI H., TOPÇUOĞLU P., et al.

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

130. ALLOJENEİK KÖK HÜCRE NAKİL ÖNCESİ FAZLAKİLOLU OBEZ OLMANIN SAĞKALIM VE NÜKS İLEİLİŞKİSİ

ATİLLA E., ATACA ATİLLA P., CEYLAN A., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

42.ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 19 - 22 October 2016

131. ALLOJENEİK KÖK HÜCRE NAKLİ HASTALARIMIZDAGELİŞEN KATATER TROMBOZLARI

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., TOPRAK S. K., YÜKSEL M., et al.

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

132. PRİMER MYELOFİBROZİS TE ALLOJENEİK KÖKHÜCRE NAKLİ TEK MERKEZ DENEYİMİ

CENGİZ G. S., GÜNDÜZ M., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., İLHAN O., et al.

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

133. AKUT LENFOSİTİK LÖSEMİDE ALL SANTRAL SİNİRSİSTEMİ SSS TUTULUMUNA YAKLAŞIM

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

42.Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

134. PERİFERİK T HÜCRELİ LENFOMALARDA OTOLOGHEMATOPOETİK KÖK HÜCRE TRANSPLANTASYONU TEK MERKEZ DENEYİMİ

ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

135. Anti HLA Antikor Varlığının Allojeneik Kök Hücre Nakli Yapılan Hastalarda Engrafman Üzerine Etkisi: Tek Merkez Deneyimi

MERTER M., AYDOĞAN M., TEKEŞ M. A., ŞAHİN U., AYYILDIZ Ö. M., KOCABAY H. E., et al.

42. Ulusal Hematoloji Kongresi, Antalya, Turkey, 19 - 22 October 2016, pp.60-61, (Summary Text)

136. BEING OVERWEIGHT PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IS RELATED TO BETTER SURVIVAL

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., AKAN H., et al.

78.th Annual Meeting of the Japanese Society of Hematology, 13 - 15 October 2016

137. IS IT POSSIBLE TO DIAGNOSE LOW RISK MYELODYSPLASTIC SYNDROME MDS BY FLOW CYTOMETRY

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAN H., BEKSAÇ M., et al.

EHA, 9 - 12 June 2016

138. OUR APPROACH TO HAIRY CELL LEUKEMIA HCL 31 YEARS OF EXPERIENCE

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

EHA, 9 - 12 June 2016

139. CD34 POSITIVE CELL COUNT DETECTED BY MULTI COLOR FLOW CYTOMETRY MFC AFTER FIRST INDUCTION THERAPY IN ACUTE MYELOID LEUKEMIA AML EFFECTS ON SURVIVAL AND RELAPSE

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

EHA, 9 - 12 June 2016

140. MANAGEMENT AND OUTCOME OF CENTRAL NERVOUS SYSTEM CNS INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKEMIA ALL PRE AND POST TRANSPLANT Conference 21st Congress of the European Hematology AssociationLocation Copenhagen DENMARK

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

21st Congress of the European-Hematology-AssociationLocation: Copenhagen, DENMARK, 9 - 12 June 2016, vol.101

141. BEING OVERWEIGHT OBESE PRIOR TO ALLOJENEIK HEMATOPOIETIC STEM CELL TRANSPLANTATION ALLO HSCT IS RELATED TO BETTER OVERALL SURVIVAL OS AND DECREASED NON RELASE MORTALITY

ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., AKAN H., et al.

EHA, 9 - 12 June 2016, (Summary Text)

142. EXTRACORPOREAL PHOTOPHERESIS SAFE AND EFFECTIVE FOR THE TREATMENT OF MYCOSIS FUNGOIDES

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAY B. N., ŞANLI H., et al.

EHA, 9 - 12 June 2016, (Summary Text)

143. THROMBOSIS IN PAROXYSMAL NOCTURNAL HEMOGLOBULINURIA PATIENTS SINGLE CENTER EXPERIENCE

MERTER M., ŞAHİN U., GÜNDÜZ M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., İLHAN O.

24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 May 2016

144. THERAPEUTIC THROMBOCYTAPHERESIS HIGHER PLATELET COUNTS SHOULD MATTER

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 May 2016

145. ARE AGE AND JAK2V617F MUTATION RELATED TO THROMBOSIS IN CHRONIC MYELOPROLIFERATIVE DISEASES

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., AKAN H., et al.

24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 May 2016

146. THERAPEUTIC PLASMA EXCHANGE FOR THROMBOTIC MICROANGIOPATHY

ATİLLA E., ATACA ATİLLA P., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 May 2016

147. Age as a dicision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

ASCO, 3 - 07 June 2016, (Summary Text)

148. Effect of Cytomegalovirus Reactivation on Prognosis After Allogeneic Transplantation for Acute Leukemia with Active Disease Conditioned with a Sequential Regimen and Anti Thymocyte Globulin

GÜNDÜZ M., YÜKSEL M., ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.

42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, 3 - 06 April 2016

149. THE EFFICACY OF TYROSINE KINASE INHIBITORS WITH STEROID IN Ph ACUTE LYMPHOBLASTIC LEUKEMIA

GÜRMAN G., MERTER M., ATİLLA E., ŞAHİN U., TOPÇUOĞLU P., ARSLAN Ö., et al.

ASCO, 3 - 07 June 2016, (Summary Text)

150. Succesfull treatment in primary central nervous system lymphoma

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., İLHAN O., et al.

ASCO, 3 - 07 June 2016, (Summary Text)

151. AKTİF HASTALIKLI AKUT LÖSEMİDE ATG VEHAZIRLIK REJİMİ İLE ALLOJENİK NAKİL SONRASICMV REAKTİVASYONUNUN PROGNOZA ETKİSİ

GÜNDÜZ M., ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

9.Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 3 - 05 March 2016

152. PAROKSİSMAL NOKTÜRNAL HEMOGLOBİNÜRİHASTALARINDA ALLOJENEİK HEMATOPOETİK KÖKHÜCRE NAKLİ TEK MERKEZ DENEYİMİ

NARLI ÖZDEMİR Z., TOPRAK S. K., TOPÇUOĞLU P., ŞAHİN U., GÜNDÜZ M., ATİLLA E., et al.

9.Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 3 - 05 March 2016

153. Efficacy of High Dose Corticosteroid Premedication for the Prevention of Anti thymocyte Globulin Related Side Effects

MERTER M., ŞAHİN U., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.

42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation Location, 1 - 02 March 2016

154. Clinical Characteristics and Frequency of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

ŞAHİN U., YÜKSEL M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Cyprus (Kktc), 1 - 02 March 2016, (Summary Text)

155. Safety and Efficacy of Obinutuzumab Plus Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia Subgroup Analysis of the Green Study

İLHAN O.

blood journal, 3 - 05 December 2015

156. NILOTINIB RESULTS IN IMPROVED RATES OF MOLECULAR RESPONSE IN TURKISH NEWLY DIAGNOSED CML CP PATIENTS A 24 MONTH UPDATE

SAYDAM G., HAZNEDAROĞLU İ. C., İLHAN O., KAYNAR L., ALİ R., GÜVENÇ B., et al.

HAEMATOLOGICA, 11 - 14 June 2015

157. MULTICENTER RETROSPECTIVE ANALYSIS OF TURKISH PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS

İLHAN O., SAYDAM G., HAZNEDAROĞLU İ. C., ÜNAL A., UĞUR BİLGİN A.

HAEMATOLOGICA, 11 - 14 June 2015

158. Does chronic lymphocytic leukemia occur in younger adults in Turkey

ARSLAN Ö., TOPÇUOĞLU P., ATİLLA E., ÖZCAN M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

JOURNAL OF CLINICAL ONCOLOGY, 29 May - 02 June 2015

159. Allogeneic stem cell transplantation results in our myelodysplastic syndrome MDS patients

ATACA P., İLHAN O., ARSLAN Ö., TOPÇUOĞLU P., ATİLLA E., AKAN H.

JOURNAL OF CLINICAL ONCOLOGY, 29 May - 02 June 2015, (Summary Text)

160. Azacitidine in combination with ATRA valproic acid in elderly AML patients

ÖZCAN M., CİVRİZ BOZDAĞ S., İLHAN O., YÜKSEL M., ATACA P., ATİLLA E., et al.

JOURNAL OF CLINICAL ONCOLOGY, 29 May - 02 June 2015

161. CML leukemic stem cell CML LSC Its existence in patients who achieved cytogenetic molecular response under treatment of TKI

İLHAN O., TOPRAK S. K., USLU A., ATİLLA E., ARSLAN Ö., ÖZCAN M., et al.

JOURNAL OF CLINICAL ONCOLOGY, 29 May - 02 June 2015

162. Autologous Stem Cell Transplantation in Elderly Patients 60 years with Myeloma or Lymphoma Single Center Experience

gündüz m., ATACA P., ATİLLA E., gültekin p., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

BONE MARROW TRANSPLANTATION, 22 - 25 March 2015

163. allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Single Centre Experienc

ŞAHİN U., MERTER M., ATİLLA E., TOPÇUOĞLU P., TOPRAK S. K., İLHAN O., et al.

BONE MARROW TRANSPLANTATION, 22 - 25 March 2015

164. Different Doses of Anti Thymocyte Globulin ATG in the Conditioning Regimen for Allogeneic Hematopoetic Stem Cell Transplantation

gültekin p., ateşağaoğlu b., MERTER M., TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

BONE MARROW TRANSPLANTATION, 22 - 25 March 2015

165. Is it possible to overcome the catastrophic complications of Hematopoietic Stem Cell Transplantation HSCT using Plasma Exchange PE A Single Center s Experience

YÜKSEL M., gültekin p., bay m., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

BONE MARROW TRANSPLANTATION, 22 - 25 March 2015, (Summary Text)

166. upper and lower respiratory tract infections by respiratory viruses in adult recipients of allogeneic hematopoeitic stem cell transplantation Allo HSCT Single center

ŞAHİN D., ATİLLA E., USLU A., ATACA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

BONE MARROW TRANSPLANTATION, 22 - 25 March 2015

167. Allogeneic Stem Cell Transplantation for Hodgkin and non Hodgkin Lymphoma Single center experience

ATİLLA E., MERTER M., ATACA P., TOPRAK S. K., YÜKSEL M., CİVRİZ BOZDAĞ S., et al.

BONE MARROW TRANSPLANTATION, 22 - 25 March 2015

168. Erythrocytosis following allogeneic hematopoietic stem cell transplantation in six cases

gültekin p., ATACA P., ATİLLA E., TOPRAK S. K., İLHAN O., TOPÇUOĞLU P., et al.

BONE MARROW TRANSPLANTATION, 22 - 25 March 2015

169. Effect of pretransplant body mass index on the clinical outcome after allogeneic stem cell transplantation in patients with hematologic malignancies a single center experience

GÖKMEN A., ender s., YÜKSEL M., İLHAN O., ARSLAN Ö., ÖZCAN M.

BONE MARROW TRANSPLANTATION, 22 - 25 March 2015

170. HLA A allele mismatch 7 8 or 9 10 is the second best option after 8 8 or 10 10 matched unrelated donors An analysis on results from Turkish centers

BEKSAÇ M., TOPÇUOĞLU P., ARAT M., İLHAN O., GÜRMAN G., zafer g.

BONE MARROW TRANSPLANTATION, 22 - 25 March 2015, (Summary Text)

171. Characterization and MicroRNA Expression Profile Analysis of Mesenchymal Stem Cells Derived From Myelodysplastic Syndrome and Acute myeloid leukemia AML Patients and Comparison with Healthy Controls

özdoğan h., ATALAY A., İLHAN O.

BONE MARROW TRANSPLANTATION, 22 - 25 March 2015, (Summary Text)

172. Upper and Lower Respiratory Tract Infections by Respiratory Viruses by Respiratory Viruses in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Single Center Experience

ŞAHİN D., ATİLLA E., CİVRİZ BOZDAĞ S., ATACA P., TOPRAK S. K., TOPÇUOĞLU P., et al.

41th EBMT Meeting, 22 - 25 March 2015, (Summary Text)

173. Generic Bioequivalent Melphalan Has Similar Efficacy and Toxicity but Lower Cost in the Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation 22 25 March 2015 Bone Marrow Transplant 2015 50 S1 S440

TOPÇUOĞLU P., GÜLTAY D., ÖZTÜRK N., KILIÇ Ö., OKAY M., ERASLAN KARADAĞ Y., et al.

41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 March 2015, (Summary Text)

174. Impact of Pre transplant Serum Ferritin on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia

UĞUR Ş., ERDAL H., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 March 2015, (Full Text)

Books 1

1. Editöryal

İLHAN O., TOPRAK S. K.

in: Hematoloji ve COVID-19 - 2020 (Kitap Editörlüğü), İlhan Osman, Toprak Selami Koçak, Editor, Türkiye Klinikleri, Ankara, pp.1-116, 2020

Metrics

Publication

429

Publication (WoS)

177

Publication (Scopus)

228

Citation (Scopus)

4541

H-Index (Scopus)

Citation (Scholar)

6923

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sobiad)

H-Index (Sobiad)

Citation (Sum Other)

Total Citation Count

4588

Publications & Works